COVID-19 Vaccines Approved for Limited Use
NCT04437875

Developer/Manufacturer :
Binnopharm
Researcher :
Gamaleya Research Institute
Vaccine/Treatment Type :
Non-Replicating Viral Vector
NCT04313127

Developer/Manufacturer :
Cansino Biologics
Researcher :
Beijing Institute of Biotechnology / National Research Council (Canada)
Vaccine/Treatment Type :
Non-Replicating Viral Vector
NCT04352608

Developer/Manufacturer :
Sinovac Biotech / PT Bio Farma
Researcher :
Instituto Butantan
Vaccine/Treatment Type :
Inactivated Virus
COVID-19 Vaccine & Treatment Statistics
Treatments & Vaccines | Treatments |
---|
Antibodies | 82 |
Antivirals | 32 |
Cell-Based Therapy | 35 |
Device | 10 |
DNA - Based | 21 |
Inactivated Virus | 19 |
Live Attenuated Virus | 4 |
Non-Replicating Viral Vector | 29 |
Protein Subunit | 82 |
Replicating Bacterial Vector | 2 |
Replicating viral vector | 22 |
RNA- Based Treatments | 6 |
RNA- Based Vaccine | 31 |
Scanning Compounds to Repurpose | 21 |
Virus Like Particle | 22 |
Others | 152 |
Final | 570 |
Treatment Trials Active or Dormant
Healthy Confirmed | Healthy or Suspected | Suspected or Unclear | Final |
---|
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
1000 | 569 | 231 | 1800 |
COVID-19 Vaccines & Treatments (India)
Over 30 organizations are trying to develop a vaccine to fight COVID-19.
World Health Organization (WHO) has already approved seven vaccine candidates for India.
3
0
2
1
1
0
Vaccine Tracker
-
Developer
Bharat Biotech International Limited
-
Researcher
ICMR - National Institute of Virology, Pune
-
Vaccine Candidate
CTRI/2020/07/026300
-
Phase
Phase I / Phase II
-
Developer
Cadila Healthcare Ltd.
-
Researcher
Cadila Healthcare Ltd.
-
Vaccine Candidate
CTRI/2020/07/026352
-
Phase
Phase I / Phase II
-
Developer
Cadila Pharmaceuticals Ltd.
-
Researcher
CSIR
-
Vaccine Candidate
CTRI/2020/04/024846
-
Phase
Phase III
-
Developer
Green Signal Biopharma Ltd.
-
Researcher
JIPMER
-
Vaccine Candidate
CTRI/2020/04/024833
-
Phase
N/A
-
Developer
Haffkine Institute for Training Research & Testing
-
Researcher
Haffkine Institute for Training Research & Testing
-
Vaccine Candidate
CTRI/2020/05/025013
-
Phase
Phase II
-
Developer
Indian Immunologicals Limited
-
Researcher
Griffith University, Australia
-
Vaccine Candidate
Pre-Clinical
-
Phase
N/A
-
Developer
Mynvax
-
Researcher
Indian Institute of Science (Bengaluru)
-
Vaccine Candidate
Pre-Clinical
-
Phase
N/A
-
Developer
Panacea Biotec Limited
-
Researcher
Refana Inc, US
-
Vaccine Candidate
Pre-Clinical
-
Phase
N/A
-
Developer
Serum Institute of India
-
Researcher
National Institute for Research in Tuberculosis
-
Vaccine Candidate
CTRI/2020/06/025854
-
Phase
N/A
-
Developer
Serum institute of India & AstraZeneca
-
Researcher
University of Oxford
-
Vaccine Candidate
CTRI/2020/04/024749
-
Phase
Phase III
Developer | Researcher | Vaccine Candidate | Phase |
---|---|---|---|
Bharat Biotech International Limited | ICMR - National Institute of Virology, Pune | CTRI/2020/07/026300 | Phase I / Phase II |
Cadila Healthcare Ltd. | Cadila Healthcare Ltd. | CTRI/2020/07/026352 | Phase I / Phase II |
Cadila Pharmaceuticals Ltd. | CSIR | CTRI/2020/04/024846 | Phase III |
Green Signal Biopharma Ltd. | JIPMER | CTRI/2020/04/024833 | N/A |
Haffkine Institute for Training Research & Testing | Haffkine Institute for Training Research & Testing | CTRI/2020/05/025013 | Phase II |
Indian Immunologicals Limited | Griffith University, Australia | Pre-Clinical | N/A |
Mynvax | Indian Institute of Science (Bengaluru) | Pre-Clinical | N/A |
Panacea Biotec Limited | Refana Inc, US | Pre-Clinical | N/A |
Serum Institute of India | National Institute for Research in Tuberculosis | CTRI/2020/06/025854 | N/A |
Serum institute of India & AstraZeneca | University of Oxford | CTRI/2020/04/024749 | Phase III |
Treatment Tracker
Abu Dhabi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Serious Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
80
Abu Dhabi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
45000
Abu Dhabi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
SOC, Stem cells
-
Trial Participants
146
Abu Dhabi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Accra
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
6400
Accra
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Mortality, Hospital Discharge, Pneumonia or ARDS, Distress
-
Treatment
HCQ, HCQ + LPV/r, LPV/r, SOC
-
Trial Participants
6400
Accra
-
COVID-19 status
Healthy
-
Outcome
Mortality, Pneumonia or ARDS, Distress
-
Treatment
HCQ, HCQ + LPV/r, LPV/r, SOC
-
Trial Participants
6400
Accra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Adana
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Addis Ababa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Afyonkarahisar
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Fever, Adverse Events, Ferritin, Lymphocyte Count, D-Dimer, Heart Rate, PaO2-FiO2, SpO2, Respiratory Rate, Radiographic Findings
-
Treatment
Ivermectin, SOC
-
Trial Participants
60
Aguascalientes
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + Ivermectin, Ivermectin
-
Trial Participants
108
Aichi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
FPV, SOC
-
Trial Participants
86
Aichi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Aichi
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
FPV + Corticosteroids
-
Trial Participants
69
Al Iskandariyah
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Imatinib, SOC
-
Trial Participants
30
Al Madinah
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
FPV, SOC
-
Trial Participants
576
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
702
Alabama
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
DHODH inhibitor, SOC
-
Trial Participants
100
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Alabama
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
200
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
NA
-
Trial Participants
60
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
208
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Fever, Serious Adverse Events, Platelet Count, ALT, AST, Albumin, Bilirubin, Blood Pressure, Heart Rate, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
Alabama
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
mAb, SOC
-
Trial Participants
390
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, ECG, SpO2
-
Treatment
Other, SOC
-
Trial Participants
150
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Alabama
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
45
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Alabama
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Alabama
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization
-
Treatment
Inhaled solution + Other, SOC
-
Trial Participants
44
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Icatibant + Remdesivir, Other + Remdesivir, PDE4 inhibitor + Remdesivir, Remdesivir, VE-PTP inhibitor + Remdesivir
-
Trial Participants
1500
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6
-
Treatment
Other, SOC
-
Trial Participants
100
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Treatment-emergent Adverse Events
-
Treatment
NA
-
Trial Participants
100
Alabama
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Treatment-emergent Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
436
Alabama
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Anti SARS-COV-2 Titers, Antibodies
-
Treatment
HCQ, SOC
-
Trial Participants
58
Alagoas
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
HCQ, SOC
-
Trial Participants
1300
Alagoas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
Alaska
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
70
Alava
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Alava
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Albacete
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Albacete
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Alberta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
LPV/r, SOC
-
Trial Participants
2900
Alberta
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality
-
Treatment
TCZ
-
Trial Participants
30
Alberta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization
-
Treatment
HCQ, SOC
-
Trial Participants
70
Alberta
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Lymphocyte Count, Platelet Count
-
Treatment
Vitamins
-
Trial Participants
64
Alberta
-
COVID-19 status
Confirmed, Suspected Or Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Blood pH
-
Treatment
HCQ, SOC
-
Trial Participants
1309
Alberta
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
ARBs, SOC
-
Trial Participants
1372
Alberta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
148
Alberta
-
COVID-19 status
Suspected
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, SpO2
-
Treatment
Positioning, SOC
-
Trial Participants
596
Alberta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
100
Alberta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1200
Alborz
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Anti SARS-COV-2 Titers
-
Treatment
SOC, Vaccine
-
Trial Participants
500
Alborz
-
COVID-19 status
Confirmed
-
Outcome
Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Alternative therapy
-
Trial Participants
48
Alessandria
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings
-
Treatment
TCZ
-
Trial Participants
400
Alicante
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Alicante
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Adverse Events
-
Treatment
Nutrition, SOC
-
Trial Participants
40
Alicante
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Amazonas
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Amazonas
-
COVID-19 status
NA
-
Outcome
Adverse Events, Natural Killer Cell Count
-
Treatment
NA
-
Trial Participants
152
Amazonas
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Corticosteroids, SOC
-
Trial Participants
416
Amman
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
45000
Amman
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Radiographic Findings
-
Treatment
Stem cells
-
Trial Participants
5
Amman
-
COVID-19 status
Healthy
-
Outcome
IL-1, IL-6, Tumor Necrosis Factor (Any)
-
Treatment
Vitamins
-
Trial Participants
100
Amman
-
COVID-19 status
Healthy
-
Outcome
IL-1, IL-6, Tumor Necrosis Factor (Any)
-
Treatment
Nutrition, SOC
-
Trial Participants
100
Amman
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Adverse Events
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
200
Amman
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, HCQ + Other
-
Trial Participants
58
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation
-
Treatment
ARBs, SOC
-
Trial Participants
651
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Fever, Other Mild Symptoms, Anti SARS-COV-2 Titers, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
1500
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
mAb
-
Trial Participants
80
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Amsterdam
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission
-
Treatment
Plasma-based therapy
-
Trial Participants
690
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, PaO2-FiO2
-
Treatment
IFN, SOC
-
Trial Participants
390
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS
-
Treatment
SOC, Vaccine
-
Trial Participants
NA
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, ALT, Albumin, Bilirubin, PaO2-FiO2
-
Treatment
NA
-
Trial Participants
386
Amsterdam
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-2, IL-6, IL-8, LDH, Radiographic Findings
-
Treatment
TCZ
-
Trial Participants
NA
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life
-
Treatment
SOC, TCZ
-
Trial Participants
450
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
mAB, SOC
-
Trial Participants
80
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge
-
Treatment
Other, SOC
-
Trial Participants
120
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2
-
Treatment
HCQ, SOC
-
Trial Participants
8
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Amsterdam
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
ARBs, SOC
-
Trial Participants
641
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ
-
Trial Participants
12
Amsterdam
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Fever, Adverse Events, C-Reactive Protein, Respiratory Rate
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
60
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
426
Amsterdam
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, PaO2-FiO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Anesthetic
-
Trial Participants
20
Amsterdam
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Dyspnea, Adverse Events, Heart Rate, PaO2-FiO2, Quality of Life
-
Treatment
Device, SOC
-
Trial Participants
13
Amsterdam
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Adverse Events, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Renal Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
124
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
Monocyte Count
-
Treatment
SOC, Vaccine, Vaccine + Bisphosphonate, Vaccine + Vaccine
-
Trial Participants
100
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
1600
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
430
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
NA
-
Trial Participants
950
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Positioning, SOC
-
Trial Participants
342
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Albumin, PaO2-FiO2
-
Treatment
NA
-
Trial Participants
386
Amsterdam
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, Ferritin, IL-6, IL-8, Radiographic Findings
-
Treatment
TCZ
-
Trial Participants
354
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events
-
Treatment
Vaccine
-
Trial Participants
10078
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
Amsterdam
-
COVID-19 status
Healthy
-
Outcome
Monocyte Count
-
Treatment
Vaccine + Bisphosphonate, Vaccine + Vaccine
-
Trial Participants
NA
Amsterdam
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Secondary CoViD-19 Re-infection, Fever, Other Mild Symptoms
-
Treatment
SOC, Vaccine
-
Trial Participants
2014
Amsterdam
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Ancona
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, HCQ + JAKi
-
Trial Participants
116
Andhra Pradesh
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
Nutrition, SOC
-
Trial Participants
124
Anhui
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Lung Inflamation
-
Treatment
SOC, TCM
-
Trial Participants
100
Anhui
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
60
Anhui
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
FPV, SOC
-
Trial Participants
210
Anhui
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
750
Anhui
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
200
Anhui
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
SOC, TCZ
-
Trial Participants
188
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, SpO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
177
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Fever, Adverse Events, Ferritin, Lymphocyte Count, D-Dimer, Heart Rate, PaO2-FiO2, SpO2, Respiratory Rate, Radiographic Findings
-
Treatment
Ivermectin, SOC
-
Trial Participants
60
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings
-
Treatment
Antivirals + Antimalarial + Antibiotics + Other, SOC
-
Trial Participants
50
Ankara
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Other, SOC
-
Trial Participants
200
Ankara
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, Procalcitonin, Fibrinogen
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
60
Ankara
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Ankara
-
COVID-19 status
NA
-
Outcome
Serious Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
43998
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS
-
Treatment
Other, SOC
-
Trial Participants
60
Ankara
-
COVID-19 status
Resolved
-
Outcome
6-Minute Walking Distance
-
Treatment
Exercise, Rehabilitation
-
Trial Participants
122
Ankara
-
COVID-19 status
Unclear
-
Outcome
Organ Failure or Dysfunction (SOFA), PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
60
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
140
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + Zinc + Vitamins + AZT
-
Trial Participants
200
Ankara
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
Ankara
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Monitoring, SOC
-
Trial Participants
100
Ankara
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospital Discharge, Viral Load or Clearance
-
Treatment
FPV, FPV + AZT, HCQ, HCQ + AZT, HCQ + FPV
-
Trial Participants
1000
Ankara
-
COVID-19 status
Confirmed
-
Outcome
Dyspnea, Other Mild Symptoms
-
Treatment
Other, SOC
-
Trial Participants
34
Antalya
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Other, SOC
-
Trial Participants
200
Antananarivo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, Other + Vitamins, SOC
-
Trial Participants
60
Antioquia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Igs, Plasma based therapy, SOC
-
Trial Participants
75
Antwerp
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, Radiographic Findings, Hypoxia
-
Treatment
Anakinra, Anakinra + Siltuximab, Anakinra + TCZ, Siltuximab, SOC, TCZ
-
Trial Participants
342
Antwerp
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
260
Aomori
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Other, SOC
-
Trial Participants
40
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
702
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Arizona
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1000
Arizona
-
COVID-19 status
NA
-
Outcome
ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
AZT + Antibiotics
-
Trial Participants
25
Arizona
-
COVID-19 status
Healthy
-
Outcome
Mortality, Serious Adverse Events, Interferon (Any), Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
6578
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2
-
Treatment
Merimepodib + Remdesivir, Remdesivir
-
Trial Participants
80
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
186
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Fever
-
Treatment
Other, SOC
-
Trial Participants
40
Arizona
-
COVID-19 status
NA
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
Natural Killer Cells, SOC
-
Trial Participants
86
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
mAb, SOC
-
Trial Participants
300
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Viral Load or Clearance
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
500
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Arizona
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Anticoagulants, SOC
-
Trial Participants
4000
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
479
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Hormone therapy, SOC
-
Trial Participants
198
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate
-
Treatment
Non-invasive respiratory support
-
Trial Participants
30
Arizona
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin, LDH
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Arizona
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
Arizona
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
Arizona
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
FPV, SOC
-
Trial Participants
50
Arizona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH
-
Treatment
Colchicine, SOC
-
Trial Participants
6000
Arkansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Arkansas
-
COVID-19 status
NA
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
Natural Killer Cells, SOC
-
Trial Participants
86
Arkansas
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Serious Adverse Events
-
Treatment
Anticoagulants, SOC
-
Trial Participants
600
Arkansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Remdesivir + Costimulation blocker, Remdesivir + mAb, Remdesivir + Other
-
Trial Participants
2160
Arkansas
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Deep Vein Thrombosis or Pulmonary Embolism, Renal Outcome (Unspecified)
-
Treatment
Other
-
Trial Participants
366
Arkansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Hormone therapy, SOC
-
Trial Participants
198
Arkansas
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Arkansas
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Arkansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH
-
Treatment
Colchicine, SOC
-
Trial Participants
6000
Astana
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy
-
Trial Participants
200
Astana
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
244
Asturias
-
COVID-19 status
NA
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Ferritin, Lymphocyte Count, Neutrophils
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
208
Asturias
-
COVID-19 status
NA
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, MCP-1, Dendritic Cell Count, D-Dimer, Coagulation Test, ALT, Glucose, LDH
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
278
Asturias
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Distress
-
Treatment
Other, SOC
-
Trial Participants
100
Asturias
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Asturias
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Asturias
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Asturias
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Asyut
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Adverse Events, IgG, IgM or IgA
-
Treatment
Igs
-
Trial Participants
100
Athens
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, IL-1, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), Monocyte Count
-
Treatment
Antibiotics
-
Trial Participants
90
Athens
-
COVID-19 status
NA
-
Outcome
Other Mild Symptoms, Organ Failure or Dysfunction (SOFA)
-
Treatment
Anakinra + Cotrimoxazole
-
Trial Participants
400
Athens
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
NA
-
Trial Participants
60
Athens
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), PaO2-FiO2, Radiographic Findings
-
Treatment
Anakinra, TCZ
-
Trial Participants
40
Athens
-
COVID-19 status
NA
-
Outcome
Dyspnea, Other Mild Symptoms, Quality of Life, Depression, Anxiety
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
100
Athens
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
60
Athens
-
COVID-19 status
Healthy
-
Outcome
IgG, IgM or IgA, Radiographic Findings, Cardiac Outcome (Unspecified)
-
Treatment
SOC, Vaccine
-
Trial Participants
900
Athens
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Cough, Dyspnea
-
Treatment
Antibiotics
-
Trial Participants
90
Athens
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Non-invasive Ventilation
-
Treatment
Remdesivir, SOC
-
Trial Participants
400
Athens
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Athens
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, IgG, IgM or IgA, Antibodies, Radiographic Findings, Cardiac Outcome (Unspecified)
-
Treatment
SOC, Vaccine
-
Trial Participants
NA
Athens
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Hormone therapy, SOC
-
Trial Participants
60
Athens
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Deep Vein Thrombosis or Pulmonary Embolism, C-Reactive Protein, White Blood Cell Count, Erythrocyte Sedimentation Rate, D-Dimer, Creatinine Phosphokinase, Fibrinogen, ALT, Bilirubin, Urine Sample, Blood Pressure, PaO2-FiO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Hormone therapy, SOC
-
Trial Participants
60
Athens
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA)
-
Treatment
Anakinra, TCZ
-
Trial Participants
40
Atlantico
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
Atlantico
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Aude
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-2, PaO2-FiO2, Patient Positioning
-
Treatment
Other, SOC
-
Trial Participants
30
Badajoz
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Baden-Wurttemberg
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, PaO2-FiO2
-
Treatment
SOC, TCZ
-
Trial Participants
200
Baden-Wurttemberg
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, IL-6, D-Dimer, Urine Sample
-
Treatment
ECMO, ECMO + Cytokine removal
-
Trial Participants
80
Baden-Wurttemberg
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, IL-6
-
Treatment
ECMO, ECMO + Cytokine removal
-
Trial Participants
30
Baghdad
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
HCQ + AZT, HCQ + AZT + Other
-
Trial Participants
16
Baghdad
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Baghdad
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
HCQ + AZT, HCQ + Plasma based therapy + AZT
-
Trial Participants
49
Baghdad
-
COVID-19 status
NA
-
Outcome
Mortality
-
Treatment
Ivermectin + Antibiotics, SOC
-
Trial Participants
140
Bahia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
HCQ, SOC
-
Trial Participants
1300
Bahia
-
COVID-19 status
Healthy
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Vaccine
-
Trial Participants
10300
Bahia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Bahia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Dexamethasone, SOC
-
Trial Participants
299
Bahia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, D-Dimer, Troponin
-
Treatment
Anticoagulants
-
Trial Participants
600
Bahia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
Baleares
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Barcelona
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, C-Reactive Protein, Ferritin, White Blood Cell Count, D-Dimer, LDH, Cardiac Outcome (Unspecified)
-
Treatment
Corticosteroids, SOC
-
Trial Participants
300
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, ALT, Bilirubin, LDH, SpO2, Hypoxemia
-
Treatment
Corticosteroids, Siltuximab
-
Trial Participants
200
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
420
Barcelona
-
COVID-19 status
Resolved
-
Outcome
NA
-
Treatment
Corticosteroids
-
Trial Participants
120
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Treatment-emergent Adverse Events, ECG
-
Treatment
SOC, Trimodulin
-
Trial Participants
164
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG
-
Treatment
Other
-
Trial Participants
46
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Igs
-
Trial Participants
100
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Distress
-
Treatment
Other, SOC
-
Trial Participants
100
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Barcelona
-
COVID-19 status
Resolved
-
Outcome
Quality of Life, Depression, Anxiety
-
Treatment
Rehabilitation, SOC
-
Trial Participants
102
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Barcelona
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
Barcelona
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, ECG
-
Treatment
Antivirals, SOC
-
Trial Participants
200
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Anticoagulants
-
Trial Participants
164
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
116
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin, Coagulation Test, ALT, AST, Albumin, Bilirubin, Glucose, SpO2, Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
SOC, TCZ + mAb
-
Trial Participants
24
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
380
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Treatment-emergent Adverse Events, CD4, PaO2-FiO2, Radiographic Findings
-
Treatment
HCQ + Antivirals, SOC
-
Trial Participants
2300
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
102
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Anakinra, SOC
-
Trial Participants
180
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Adverse Events
-
Treatment
Corticosteroids, SOC
-
Trial Participants
72
Barcelona
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events
-
Treatment
Vaccine
-
Trial Participants
10078
Barcelona
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Barcelona
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Cytokine removal, SOC
-
Trial Participants
40
Barcelona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Barnet
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Barnsley
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
150
Basel-Stadt
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
mAb
-
Trial Participants
NA
Bayern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test
-
Treatment
Anticoagulants, SOC
-
Trial Participants
400
Bayern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Non-invasive Ventilation, Cough, Other Mild Symptoms, Adverse Events, Radiographic Findings
-
Treatment
Antivirals, SOC
-
Trial Participants
342
Beijing
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein, IL-6, PaO2-FiO2, Radiographic Findings
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
45
Beijing
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
FPV, SOC
-
Trial Participants
256
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, C-Reactive Protein, Creatinine Phosphokinase, ALT, CD4, CD8
-
Treatment
SOC, Stem cells
-
Trial Participants
20
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism
-
Treatment
SOC, TCM
-
Trial Participants
100
Beijing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, PaO2-FiO2, Respiratory Rate
-
Treatment
SOC, TCM
-
Trial Participants
42
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, White Blood Cell Count, Monocyte Count, Hemoglobin, Erythrocyte Sedimentation Rate, Radiographic Findings
-
Treatment
LPV/r, LPV/r + TCM, TCM
-
Trial Participants
60
Beijing
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Fever, Other Mild Symptoms
-
Treatment
SOC, TCM
-
Trial Participants
2000
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
SOC, TCM
-
Trial Participants
120
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Radiographic Findings
-
Treatment
Corticosteroids, SOC
-
Trial Participants
80
Beijing
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
NA
-
Trial Participants
10
Beijing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
LPV/r, Other
-
Trial Participants
160
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
FPV, FPV + TCZ, TCZ
-
Trial Participants
150
Beijing
-
COVID-19 status
Healthy
-
Outcome
Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
422
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Fever, C-Reactive Protein, Ferritin, Radiographic Findings, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
300
Beijing
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
40
Beijing
-
COVID-19 status
NA
-
Outcome
PaO2-FiO2
-
Treatment
Non-invasive respiratory support
-
Trial Participants
200
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), C-Reactive Protein, Ferritin, IL-6, Interferon (Any), Lymphocyte Count, D-Dimer, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Coagulation Test, ALT, Albumin, Bilirubin, IgG, IgM or IgA, Blood Gas, ECG, SpO2, 6-Minute Walking Distance, Radiographic Findings, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
SOC, Stem cells
-
Trial Participants
200
Beijing
-
COVID-19 status
Healthy
-
Outcome
Mortality, Pneumonia or ARDS, Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
15000
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Adverse Events, C-Reactive Protein, Ferritin, IL-6, White Blood Cell Count, Neutrophils, Erythrocyte Sedimentation Rate, D-Dimer, Creatinine Phosphokinase, CK-MB, LDH, Antibodies, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
50
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Serious or Seconday Infections, C-Reactive Protein, Radiographic Findings
-
Treatment
FPV, HCQ + FPV, SOC
-
Trial Participants
150
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Serious or Seconday Infections, C-Reactive Protein, Radiographic Findings
-
Treatment
HCQ, SOC
-
Trial Participants
300
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events
-
Treatment
Igs, SOC
-
Trial Participants
80
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, Procalcitonin, Radiographic Findings
-
Treatment
mAb, Other
-
Trial Participants
120
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Fever, C-Reactive Protein, D-Dimer, PaO2-FiO2, Respiratory Rate, Radiographic Findings
-
Treatment
mAb
-
Trial Participants
20
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events
-
Treatment
LPV/r + IFN, SOC
-
Trial Participants
90
Beijing
-
COVID-19 status
Resolved
-
Outcome
Pneumonia or ARDS, Dyspnea, 6-Minute Walking Distance, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
160
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Erythrocyte Sedimentation Rate, CK-MB, ALT, PaO2-FiO2, Radiographic Findings
-
Treatment
Umifenovir, Umifenovir + IFN
-
Trial Participants
100
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Erythrocyte Sedimentation Rate, CK-MB, ALT, PaO2-FiO2, Radiographic Findings
-
Treatment
LPV/r, Oseltamivir, SOC, Umifenovir
-
Trial Participants
400
Beijing
-
COVID-19 status
Resolved
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Cough, Dyspnea
-
Treatment
FPV, FPV + HCQ, SOC
-
Trial Participants
150
Beijing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, C-Reactive Protein, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, ALT, PaO2-FiO2, Respiratory Rate
-
Treatment
Oseltamivir, Oseltamivir + Antivirals, Other + Oseltamivir
-
Trial Participants
60
Beijing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), PaO2-FiO2, Radiographic Findings
-
Treatment
Corticosteroids
-
Trial Participants
100
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Antibodies, PaO2-FiO2, Radiographic Findings
-
Treatment
Igs
-
Trial Participants
10
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
140
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-1, IL-2, IL-6, IL-8, CK-MB, Procalcitonin
-
Treatment
NA
-
Trial Participants
9
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, PaO2-FiO2, Respiratory Rate
-
Treatment
SOC, TCM
-
Trial Participants
550
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, 3CL Mpro, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Dendritic Cell Count, Neutrophils, Creatinine Phosphokinase, CK-MB, ALT, Urine Sample, Stool Sample, Radiographic Findings
-
Treatment
LPV/r + IFN, LPV/r + IFN + TCM
-
Trial Participants
20
Beijing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Visits or Returns to Emergency Department, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events
-
Treatment
DAA + IFN
-
Trial Participants
11
Beijing
-
COVID-19 status
Healthy
-
Outcome
Adverse Events, Antibodies
-
Treatment
mAb, SOC
-
Trial Participants
33
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Treatment-emergent Adverse Events, C-Reactive Protein, Respiratory Rate, Radiographic Findings
-
Treatment
NA
-
Trial Participants
20
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, Radiographic Findings
-
Treatment
FPV, FPV + TCZ, TCZ
-
Trial Participants
150
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
Remdesivir, SOC
-
Trial Participants
308
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
Remdesivir, SOC
-
Trial Participants
237
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), PaO2-FiO2, Respiratory Rate, Hypoxia, Hypoxemia
-
Treatment
SOC, Vitamins
-
Trial Participants
56
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
60
Beijing
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
Other
-
Trial Participants
25
Beijing
-
COVID-19 status
Confirmed
-
Outcome
PaO2-FiO2, Radiographic Findings, Hypoxia, Hypoxemia
-
Treatment
Stem cells
-
Trial Participants
24
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
50
Beijing
-
COVID-19 status
Confirmed
-
Outcome
IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
471
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
200
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Stool Sample
-
Treatment
Alternative therapy
-
Trial Participants
76
Beijing
-
COVID-19 status
NA
-
Outcome
PaO2-FiO2
-
Treatment
Non-invasive respiratory support
-
Trial Participants
20
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Cough, Fever, Dyspnea
-
Treatment
LPV/r, LPV/r + TCM
-
Trial Participants
80
Beijing
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Corticosteroids, SOC
-
Trial Participants
86
Beijing
-
COVID-19 status
Healthy
-
Outcome
Adverse Events, Radiographic Findings
-
Treatment
mAb, SOC
-
Trial Participants
12
Beijing
-
COVID-19 status
Healthy
-
Outcome
Adverse Events, Radiographic Findings
-
Treatment
mAb, SOC
-
Trial Participants
12
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, IL-6, IL-10, Tumor Necrosis Factor (Any)
-
Treatment
Other
-
Trial Participants
19
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Other Mild Symptoms, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Natural Killer Cell Count, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
20
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Other Mild Symptoms, Adverse Events, Radiographic Findings
-
Treatment
DAA, SOC
-
Trial Participants
342
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS
-
Treatment
Immunomodulators, SOC
-
Trial Participants
30
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, IL-6, IL-10, Tumor Necrosis Factor (Any)
-
Treatment
Cytokine removal
-
Trial Participants
19
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, IgG, IgM or IgA
-
Treatment
HCQ
-
Trial Participants
100
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Beijing
-
COVID-19 status
Healthy
-
Outcome
Pneumonia or ARDS, Cough, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings
-
Treatment
IFN, SOC
-
Trial Participants
450
Beijing
-
COVID-19 status
NA
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
744
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, IgG, IgM or IgA
-
Treatment
HCQ
-
Trial Participants
100
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Radiographic Findings
-
Treatment
Carrimycin, HCQ or LPV/r or Umifenovir
-
Trial Participants
520
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
SOC, TCM
-
Trial Participants
204
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough, Fever, Dyspnea
-
Treatment
SOC, TCM
-
Trial Participants
120
Beijing
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Psychological therapy
-
Trial Participants
1600
Beijing
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
TCM
-
Trial Participants
300
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, PaO2-FiO2
-
Treatment
TCM
-
Trial Participants
116
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Antimalarial, SOC
-
Trial Participants
275
Beijing
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
SOC, Stem cells
-
Trial Participants
60
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Serious or Seconday Infections, Lymphocyte Count, IgG, IgM or IgA, Blood Pressure, Heart Rate, Respiratory Rate, Radiographic Findings
-
Treatment
HCQ, SOC
-
Trial Participants
78
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Radiographic Findings
-
Treatment
LPV/r + IFN + TCM + Non-invasive respiratory support, LPV/r + Non-invasive respiratory support + IFN
-
Trial Participants
150
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
40
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever
-
Treatment
LPV/r + IFN, TCM
-
Trial Participants
348
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-1, IL-2, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, IP-10, MCP-1, MIP-1
-
Treatment
Immunomodulators, SOC
-
Trial Participants
40
Beijing
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
SOC, TCM
-
Trial Participants
300
Beijing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Other Mild Symptoms
-
Treatment
FPV
-
Trial Participants
60
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
TCM
-
Trial Participants
60
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough, Fever, Dyspnea, Respiratory Rate, Radiographic Findings
-
Treatment
IFN, SOC
-
Trial Participants
300
Beijing
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, Stem cells
-
Trial Participants
120
Beijing
-
COVID-19 status
NA
-
Outcome
ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Serious Adverse Events
-
Treatment
NA
-
Trial Participants
10
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Radiographic Findings, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
60
Beijing
-
COVID-19 status
Healthy
-
Outcome
IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
942
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever
-
Treatment
Carrimycin, LPV/r
-
Trial Participants
520
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Fever, Radiographic Findings, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
408
Beijing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever
-
Treatment
SOC, TCM
-
Trial Participants
60
Beirut
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Belfast
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Bergamo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Non-invasive Ventilation
-
Treatment
Plasma based therapy
-
Trial Participants
10
Bergamo
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
IL-1, IL-2, IL-6, IL-7, IL-10, Tumor Necrosis Factor (Any), MCP-1, IgG, IgM or IgA, Antibodies, Radiographic Findings
-
Treatment
Igs
-
Trial Participants
10
Bergamo
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Bergamo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Berlin
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
420
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Berlin
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
FPV, SOC
-
Trial Participants
256
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, PaO2-FiO2
-
Treatment
SOC, Stem cells
-
Trial Participants
64
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
220
Berlin
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, IL-6, D-Dimer, Urine Sample
-
Treatment
ECMO, ECMO + Cytokine removal
-
Trial Participants
80
Berlin
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, Ferritin, IL-6, Radiographic Findings
-
Treatment
JAKi
-
Trial Participants
15
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, PaO2-FiO2
-
Treatment
IFN, SOC
-
Trial Participants
390
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
IFN, LPV/r, Remdesivir, SOC
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Berlin
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2
-
Treatment
mAb, SOC
-
Trial Participants
270
Berlin
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
NA
-
Trial Participants
17
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
ECMO
-
Trial Participants
200
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Renal Outcome (Unspecified)
-
Treatment
Cytokine removal, SOC
-
Trial Participants
100
Berlin
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
200
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, SpO2, Respiratory Rate
-
Treatment
DAA, HCQ, SOC
-
Trial Participants
90
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Hygiene
-
Trial Participants
50
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test
-
Treatment
Anticoagulants, SOC
-
Trial Participants
400
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)
-
Treatment
Remdesivir, SOC
-
Trial Participants
440
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization
-
Treatment
HCQ, SOC
-
Trial Participants
350
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Device + Other, SOC
-
Trial Participants
600
Berlin
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
120
Berlin
-
COVID-19 status
Healthy
-
Outcome
Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Antibodies
-
Treatment
Vaccine
-
Trial Participants
120
Berlin
-
COVID-19 status
NA
-
Outcome
Serious Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
43998
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life
-
Treatment
SOC, TCZ
-
Trial Participants
450
Berlin
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Treatment-emergent Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
2500
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
230
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Antibodies
-
Treatment
JAKi
-
Trial Participants
200
Berlin
-
COVID-19 status
Unclear
-
Outcome
Adverse Events
-
Treatment
Device
-
Trial Participants
20
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), C-Reactive Protein, Troponin
-
Treatment
NA
-
Trial Participants
334
Berlin
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
59
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Fever, Other Mild Symptoms, Treatment-emergent Adverse Events, Antibodies
-
Treatment
Vaccine
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Hyper-Inflammation, Radiographic Findings
-
Treatment
JAKi
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance
-
Treatment
HCQ, SOC
-
Trial Participants
NA
Berlin
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, Ferritin, IL-6, D-Dimer, Procalcitonin, Shock, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
SOC, TCZ
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
140
Berlin
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
106
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization
-
Treatment
HCQ, SOC
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, LDH
-
Treatment
Antihypertensive, SOC
-
Trial Participants
200
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Tumor Necrosis Factor (Any), Interferon (Any), D-Dimer, Weight, Height or BMI, Troponin, Procalcitonin, LDH, IgG, IgM or IgA, Antibodies, Blood Pressure, Heart Rate, ECG, SpO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Immunomodulators, SOC
-
Trial Participants
230
Berlin
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Anticoagulants
-
Trial Participants
172
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, SpO2
-
Treatment
JAKi, SOC
-
Trial Participants
402
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Lymphocyte Count, D-Dimer, Antibodies
-
Treatment
SOC, Stem cells
-
Trial Participants
40
Berlin
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
Berlin
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Berlin
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Fever
-
Treatment
SOC, Vaccine
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Monocyte Count, Neutrophils, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose, ECG
-
Treatment
Other, SOC
-
Trial Participants
183
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT
-
Treatment
Sarilumab, SOC
-
Trial Participants
460
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Berlin
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, Weight, Height or BMI, Coagulation Test, LDH, Blood Pressure, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
Berlin
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, C-Reactive Protein, Ferritin, IL-6, IgG, IgM or IgA
-
Treatment
JAKi
-
Trial Participants
NA
Berlin
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Fever
-
Treatment
SOC, Vaccine
-
Trial Participants
NA
Berlin
-
COVID-19 status
NA
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
220
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
ARBs, SOC
-
Trial Participants
NA
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Berlin
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
284
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, SpO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
177
Berlin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Other, SOC
-
Trial Participants
1034
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, C-Reactive Protein, Ferritin, White Blood Cell Count, PaO2-FiO2
-
Treatment
Radiation therapy
-
Trial Participants
22
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), C-Reactive Protein, Hemoglobin, D-Dimer, eGFR, Glucose, Renal Outcome (Unspecified)
-
Treatment
mAb, SOC
-
Trial Participants
116
Bern
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Nutrition
-
Trial Participants
284
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism
-
Treatment
SOC, TCZ
-
Trial Participants
5
Bern
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test
-
Treatment
Anticoagulants
-
Trial Participants
200
Bern
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
90
Bern
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Non-invasive Ventilation, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
120
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Coagulation Test
-
Treatment
Anticoagulants, SOC
-
Trial Participants
1000
Bern
-
COVID-19 status
Confirmed
-
Outcome
Treatment-emergent Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
2500
Bern
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, MCP-1, Procalcitonin, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Anesthetic, SOC
-
Trial Participants
64
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Serious Adverse Events
-
Treatment
Plasma based therapy
-
Trial Participants
15
Bern
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
HCQ, LPV/r
-
Trial Participants
300
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Bern
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Bern
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
800
Bern
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Bern
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Lymphocyte Count, Procalcitonin
-
Treatment
Inhaled solution
-
Trial Participants
80
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization
-
Treatment
Vitamins
-
Trial Participants
80
Bern
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Bio-Bio
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
524
Birmingham
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Pneumonia or ARDS
-
Treatment
AZT, SOC
-
Trial Participants
800
Birmingham
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Bissau
-
COVID-19 status
Healthy
-
Outcome
Mortality
-
Treatment
SOC, Vaccine
-
Trial Participants
3400
Bissau
-
COVID-19 status
Unclear
-
Outcome
Mortality
-
Treatment
Device, SOC
-
Trial Participants
66000
Bizkaia
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Bizkaia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Bizkaia
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events
-
Treatment
Vaccine
-
Trial Participants
10078
Bizkaia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Bogota
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events
-
Treatment
NRTIs, SOC
-
Trial Participants
950
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
Ivermectin, SOC
-
Trial Participants
400
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-6, Hemoglobin, D-Dimer, Procalcitonin, AST, Bilirubin, Antibodies, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
60
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
HCQ + LPV/r or AZT, Stem cells
-
Trial Participants
40
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Bogota
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Household Members with CoViD-19, Labor Absenteeism, Adverse Events, Treatment-emergent Adverse Events
-
Treatment
NA
-
Trial Participants
10
Bogota
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
86
Bogota
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
60000
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
mAb, SOC
-
Trial Participants
800
Bogota
-
COVID-19 status
NA
-
Outcome
Mortality, Viral Load or Clearance, Adverse Events, Serious Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
1000
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Hypoxemia
-
Treatment
Other, SOC
-
Trial Participants
284
Bogota
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
Bogota
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Treatment-emergent Adverse Events
-
Treatment
HCQ + LPV/r, HCQ + LPV/r + Alternative therapy
-
Trial Participants
100
Bogota
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
231
Bogota
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Bogota
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
AZT, HCQ, LPV/r, SOC
-
Trial Participants
1200
Bolivar
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Bologna
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Bologna
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
102
Bologna
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Anticoagulants
-
Trial Participants
300
Bradford
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Bradford
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
150
Brandenburg
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test
-
Treatment
Anticoagulants, SOC
-
Trial Participants
400
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Stem cells
-
Trial Participants
90
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Antivirals, SOC
-
Trial Participants
50
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, IL-6, Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
100
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Platelet Count, Prothrombin, Fibrinogen
-
Treatment
Anticoagulants, SOC
-
Trial Participants
462
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Other, SOC
-
Trial Participants
310
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
SOC, TCZ
-
Trial Participants
60
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Fever, Treatment-emergent Adverse Events, Serious Adverse Events, IL-6, PaO2-FiO2
-
Treatment
NA
-
Trial Participants
120
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge
-
Treatment
Device, SOC
-
Trial Participants
30
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, Radiographic Findings, Depression, Anxiety
-
Treatment
Alternative therapy, SOC
-
Trial Participants
100
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Antivirals, SOC
-
Trial Participants
300
Brasilia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
HCQ, SOC
-
Trial Participants
1300
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2
-
Treatment
Other, SOC
-
Trial Participants
465
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
573
Brasilia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2
-
Treatment
HCQ, SOC
-
Trial Participants
630
Brasilia
-
COVID-19 status
Healthy
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Vaccine
-
Trial Participants
10300
Brasilia
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
219
Brasilia
-
COVID-19 status
NA
-
Outcome
Serious Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
43998
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Brasilia
-
COVID-19 status
NA
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
SOC, TCZ
-
Trial Participants
379
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Brasilia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Dexamethasone, SOC
-
Trial Participants
299
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), C-Reactive Protein
-
Treatment
Acalabrutinib
-
Trial Participants
48
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Brasilia
-
COVID-19 status
NA
-
Outcome
Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Antisense therapy, SOC
-
Trial Participants
110
Brasilia
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
60000
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
140
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
260
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
HCQ + AZT
-
Trial Participants
400
Brasilia
-
COVID-19 status
Unclear
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any)
-
Treatment
HCQ + AZT
-
Trial Participants
200
Brasilia
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
ARBs + ACEi, SOC
-
Trial Participants
700
Brasilia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
440
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, ECG, SpO2
-
Treatment
Other, SOC
-
Trial Participants
150
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
mAb, Other, SOC
-
Trial Participants
390
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
66
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
64
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, D-Dimer, Troponin
-
Treatment
Anticoagulants
-
Trial Participants
600
Brasilia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
NA
-
Treatment
Anticoagulants, SOC
-
Trial Participants
90
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
380
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Brasilia
-
COVID-19 status
Healthy
-
Outcome
Invasive Mechanical Ventilation or ECMO, Adverse Events, Heart Rate, ECG
-
Treatment
HCQ, SOC
-
Trial Participants
400
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Hormone therapy + Ivermectin + AZT, Ivermectin + AZT
-
Trial Participants
381
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Non-invasive Ventilation, Fever, SpO2, Respiratory Rate
-
Treatment
Remdesivir, Remdesivir + TCZ
-
Trial Participants
500
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Antivirals, SOC
-
Trial Participants
584
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission
-
Treatment
Antihypertensive
-
Trial Participants
240
Brasilia
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
13060
Brasilia
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
100
Brasilia
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
1000
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
100
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
Brasilia
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
2000
Brasilia
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Respiratory Rate, Hypoxia
-
Treatment
Other
-
Trial Participants
42
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)
-
Treatment
Anticoagulants, SOC
-
Trial Participants
3000
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
410
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Adverse Events, C-Reactive Protein, Renal Outcome (Unspecified)
-
Treatment
Alternative therapy, SOC
-
Trial Participants
120
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, TCZ
-
Trial Participants
129
Brasilia
-
COVID-19 status
Healthy
-
Outcome
Treatment-emergent Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
200
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin
-
Treatment
mAb, SOC
-
Trial Participants
270
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Lymphocyte Count, D-Dimer
-
Treatment
Other, SOC
-
Trial Participants
68
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, SpO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
177
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Other, SOC
-
Trial Participants
1034
Brasilia
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
420
Brasilia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization
-
Treatment
HCQ, HCQ + LPV/r, LPV/r, SOC
-
Trial Participants
1968
Brescia
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Adverse Events, Radiographic Findings
-
Treatment
Radiation therapy
-
Trial Participants
30
Brescia
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Brescia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Brescia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Anticoagulants
-
Trial Participants
300
Bristol
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
150
Bristol
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
1090
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
LPV/r, SOC
-
Trial Participants
2900
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization
-
Treatment
HCQ, SOC
-
Trial Participants
70
British Columbia
-
COVID-19 status
Healthy
-
Outcome
Adverse Events, Platelet Count, Radiographic Findings
-
Treatment
Vaccine
-
Trial Participants
20
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
British Columbia
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
ARBs, SOC
-
Trial Participants
1372
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
50
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
100
British Columbia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance
-
Treatment
Hygeine, SOC
-
Trial Participants
81
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
Non-invasive respiratory support
-
Trial Participants
200
British Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1200
British Columbia
-
COVID-19 status
Healthy
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Other Mild Symptoms, Adverse Events, Quality of Life, Distress
-
Treatment
LPV/r, SOC
-
Trial Participants
1220
Brussels
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, Radiographic Findings, Hypoxia
-
Treatment
Anakinra, Anakinra + Siltuximab, Anakinra + TCZ, Siltuximab, SOC, TCZ
-
Trial Participants
342
Brussels
-
COVID-19 status
Confirmed
-
Outcome
PaO2-FiO2
-
Treatment
Cytokine removal, SOC
-
Trial Participants
24
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
3100
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Brussels
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Serious Adverse Events, IL-1, IL-2, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Interferon (Any), Angiotensins, PaO2-FiO2, Radiographic Findings
-
Treatment
Antihypertensive, SOC
-
Trial Participants
60
Brussels
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
483
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Other, SOC
-
Trial Participants
310
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, Ferritin, IL-2, IL-7, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, Interferon (Any), MCP-1, MIP-1, White Blood Cell Count, Lymphocyte Count, PaO2-FiO2, SpO2, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2
-
Treatment
Other, SOC
-
Trial Participants
465
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Ferritin, IL-1, IL-6, PaO2-FiO2, Radiographic Findings, Hypoxia
-
Treatment
Siltuximab, TCZ
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
230
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2
-
Treatment
HCQ, SOC
-
Trial Participants
8
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Adverse Events, Serious Adverse Events
-
Treatment
HCQ
-
Trial Participants
NA
Brussels
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
1045
Brussels
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
ARBs, SOC
-
Trial Participants
1372
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, PaO2-FiO2, Radiographic Findings, Hypoxia, Distress
-
Treatment
Other, SOC
-
Trial Participants
81
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Ferritin, D-Dimer, Procalcitonin, ECG
-
Treatment
Immunomodulators
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, Respiratory Rate, Radiographic Findings
-
Treatment
SOC, TCZ
-
Trial Participants
60
Brussels
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Creatinine Phosphokinase, eGFR, Troponin, ALT, AST, Bilirubin, Glucose, ECG, 6-Minute Walking Distance, Radiographic Findings, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
AZT, SOC
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Monocyte Count, Lymphocyte Count, D-Dimer, CD4, CD8, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
200
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS
-
Treatment
Stem cells
-
Trial Participants
20
Brussels
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
260
Brussels
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Hyper-Inflammation, Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, Tumor Necrosis Factor (Any), Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, eGFR, Troponin, Fibrinogen, ALT, AST, Albumin, Bilirubin, Glucose, LDH, Radiographic Findings, Cardiac Outcome (Unspecified)
-
Treatment
Anticoagulants + Anakinra + Other, SOC
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, Ferritin, D-Dimer, Procalcitonin, Blood Gas, PaO2-FiO2, SpO2, Radiographic Findings, Hypoxia, Cardiac Outcome (Unspecified)
-
Treatment
Immunomodulators, SOC
-
Trial Participants
NA
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
Other
-
Trial Participants
80
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Serious Adverse Events, Coagulation Test
-
Treatment
Other, SOC
-
Trial Participants
60
Brussels
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
284
Brussels
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Other, SOC
-
Trial Participants
1034
Bucharest
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
FPV, SOC
-
Trial Participants
256
Bucharest
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
682
Bucharest
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Bucharest
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Bucharest
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Bucharest
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
222
Budapest
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospitalization, Other Mild Symptoms
-
Treatment
Education, Psychological therapy
-
Trial Participants
7576
Budapest
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge
-
Treatment
Other, SOC
-
Trial Participants
120
Budapest
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Budapest
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Labor Absenteeism, Fever
-
Treatment
SOC, Vaccine
-
Trial Participants
NA
Budapest
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Other Mild Symptoms, Bilirubin
-
Treatment
Plasma based therapy
-
Trial Participants
20
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Distress
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
80
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Buenos Aires
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
3000
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Buenos Aires
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Organ Failure or Dysfunction (SOFA), Adverse Events, Lymphocyte Count
-
Treatment
NSAIDs
-
Trial Participants
40
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
200
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Igs, SOC
-
Trial Participants
242
Buenos Aires
-
COVID-19 status
NA
-
Outcome
Serious Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
43998
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge
-
Treatment
Other, SOC
-
Trial Participants
140
Buenos Aires
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Troponin, LDH, Urine Sample
-
Treatment
Antihypertensive, SOC
-
Trial Participants
400
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
SOC, Vitamins
-
Trial Participants
1264
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, Ferritin, D-Dimer, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
333
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Plasma-based therapy, SOC
-
Trial Participants
36
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Antivirals, SOC
-
Trial Participants
135
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Dexamethasone, SOC
-
Trial Participants
284
Buenos Aires
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
60000
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO
-
Treatment
Device
-
Trial Participants
50
Buenos Aires
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
Colchicine, SOC
-
Trial Participants
2500
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Buenos Aires
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
NRTIs, SOC
-
Trial Participants
1378
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events, Antibodies
-
Treatment
Ivermectin, SOC
-
Trial Participants
45
Buenos Aires
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Respiratory Rate
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
210
Buenos Aires
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Buenos Aires
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
400
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Lymphocyte Count, D-Dimer
-
Treatment
Other, SOC
-
Trial Participants
68
Buenos Aires
-
COVID-19 status
Suspected
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Anticoagulants
-
Trial Participants
200
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, SpO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
177
Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
420
Burgos
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Burgos
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Bursa
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Ivermectin + Antivirals, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Other, SOC
-
Trial Participants
150
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
Alternative therapy, SOC
-
Trial Participants
50
Cairo
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Other Mild Symptoms
-
Treatment
Other, SOC
-
Trial Participants
300
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, C-Reactive Protein, IL-1, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer
-
Treatment
Hormone therapy, Hormone therapy + Other, SOC
-
Trial Participants
160
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Distress
-
Treatment
Anticoagulants
-
Trial Participants
50
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Ivermectin, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
45000
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-1, IL-6, IL-10, Tumor Necrosis Factor (Any), Platelet Count, Erythrocyte Sedimentation Rate, D-Dimer, Prothrombin, ALT, AST, Albumin, Bilirubin, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Respiratory Rate, Radiographic Findings
-
Treatment
Nutrition, SOC
-
Trial Participants
516
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
FPV, SOC
-
Trial Participants
90
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
40
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, IL-6, D-Dimer, Procalcitonin
-
Treatment
Plasma based therapy
-
Trial Participants
10
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other
-
Trial Participants
180
Cairo
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
HCQ
-
Trial Participants
200
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy, Plasma based therapy + Other, SOC
-
Trial Participants
15
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
200
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Cairo
-
COVID-19 status
NA
-
Outcome
LDH
-
Treatment
Other, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Resolved
-
Outcome
NA
-
Treatment
Corticosteroids, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
Antihypertensive, SOC
-
Trial Participants
60
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Antivirals, DAA, SOC
-
Trial Participants
240
Cairo
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
200
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Other, SOC
-
Trial Participants
200
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Distress
-
Treatment
Dexamethasone
-
Trial Participants
450
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS
-
Treatment
DAA, SOC
-
Trial Participants
50
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough
-
Treatment
HCQ, SOC
-
Trial Participants
40
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, Stem cells
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Antivirals + AZT, Ivermectin + Antivirals, Ivermectin + Antivirals + AZT, Ivermectin + HCQ
-
Trial Participants
80
Cairo
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Anti SARS-COV-2 Titers, C-Reactive Protein, IL-1, IL-6, Interferon (Any), Erythrocyte Sedimentation Rate, D-Dimer
-
Treatment
Other, SOC
-
Trial Participants
1000
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Antivirals, HCQ, Ivermectin
-
Trial Participants
300
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
HCQ, Ivermectin + Docycline
-
Trial Participants
200
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, IL-1, Tumor Necrosis Factor (Any), Respiratory Rate
-
Treatment
Alternative therapy, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
360
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
DAA, DAA + Antiviral, SOC
-
Trial Participants
60
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ + Antivirals, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Radiographic Findings
-
Treatment
FPV, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization
-
Treatment
DAA, Oseltamivir + HCQ + AZT
-
Trial Participants
250
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
30
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Dyspnea
-
Treatment
HCQ + AZT, Other
-
Trial Participants
60
Cairo
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
Other
-
Trial Participants
100
Cairo
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, C-Reactive Protein, Ferritin, IL-1, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer
-
Treatment
Other
-
Trial Participants
56
Cairo
-
COVID-19 status
NA
-
Outcome
Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate, Blood pH
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
60
Cairo
-
COVID-19 status
NA
-
Outcome
Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, Treatment-emergent Adverse Events
-
Treatment
NA
-
Trial Participants
120
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
HCQ, HCQ + Zinc
-
Trial Participants
200
Cairo
-
COVID-19 status
NA
-
Outcome
Mortality, Ferritin, IL-6, Tumor Necrosis Factor (Any), Platelet Count, Prothrombin, INR, Respiratory Rate
-
Treatment
Ivermectin + Antivirals, Non-invasive respiratory support
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Fever
-
Treatment
Other, SOC
-
Trial Participants
24
Cairo
-
COVID-19 status
NA
-
Outcome
Mortality, Viral Load or Clearance, Ferritin, IL-6, Tumor Necrosis Factor (Any), Prothrombin, PaO2-FiO2, Respiratory Rate
-
Treatment
HCQ + Antivirals, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, IL-8, Tumor Necrosis Factor (Any), PAI-1, von Wildebrandt Factor, Lymphocyte Count, Angiotensins, ACE, ACE-II, Surfactant Factor Protein, SRAGE, PaO2-FiO2, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
24
Cairo
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
60
Cairo
-
COVID-19 status
NA
-
Outcome
Hospitalization, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
SOC, Vaccine
-
Trial Participants
200
Cairo
-
COVID-19 status
Healthy
-
Outcome
Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Ivermectin, SOC
-
Trial Participants
340
Cairo
-
COVID-19 status
Confirmed, Suspected Or Healthy
-
Outcome
NA
-
Treatment
Nutrition, SOC
-
Trial Participants
60
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Fever, Radiographic Findings
-
Treatment
Nutrition, SOC
-
Trial Participants
1000
Cairo
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Other
-
Trial Participants
200
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
67
Cairo
-
COVID-19 status
Confirmed
-
Outcome
PaO2-FiO2
-
Treatment
Anticoagulants, SOC
-
Trial Participants
100
Cairo
-
COVID-19 status
Healthy
-
Outcome
Cough, Fever
-
Treatment
SOC, Vaccine
-
Trial Participants
200
Cairo
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance
-
Treatment
SOC, Vaccine
-
Trial Participants
900
Cairo
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Radiographic Findings
-
Treatment
Plasma based therapy
-
Trial Participants
20
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Platelet Count, Erythrocyte Sedimentation Rate, D-Dimer, Creatinine Phosphokinase, Troponin, Procalcitonin, LDH, SpO2, Respiratory Rate, Hypoxemia
-
Treatment
Other, SOC
-
Trial Participants
100
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
Antihypertensive, SOC
-
Trial Participants
160
California
-
COVID-19 status
Healthy
-
Outcome
Antibodies
-
Treatment
Vaccine
-
Trial Participants
25
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Adverse Events
-
Treatment
Razuprotafib, SOC
-
Trial Participants
180
California
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, Antibodies
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
24
California
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
mAb
-
Trial Participants
NA
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
California
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1000
California
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
DHODH inhibitor, SOC
-
Trial Participants
100
California
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Cardiosphere-Derived Cells, SOC
-
Trial Participants
60
California
-
COVID-19 status
Healthy
-
Outcome
Mortality, Serious Adverse Events, Interferon (Any), Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
6578
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
California
-
COVID-19 status
Healthy
-
Outcome
Labor Absenteeism, Serious Adverse Events
-
Treatment
Nutrition
-
Trial Participants
500
California
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, IL-1, IL-6, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
60
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
573
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings
-
Treatment
PDE4 + SOC, SOC
-
Trial Participants
700
California
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, D-Dimer, Electrolytes
-
Treatment
Ivermectin + Doxycycline + Zinc + Vitamins, Vitamins + Zinc
-
Trial Participants
300
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
California
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
24
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
California
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
NA
-
Trial Participants
600
California
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events
-
Treatment
HCQ + Vitamins + Zinc, SOC
-
Trial Participants
600
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Other, SOC
-
Trial Participants
160
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia
-
Treatment
Inhaled solution, SOC
-
Trial Participants
144
California
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, White Blood Cell Count, Lymphocyte Count, Platelet Count, Hemoglobin
-
Treatment
Other, SOC
-
Trial Participants
30
California
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
California
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
California
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, Vitamins
-
Trial Participants
829
California
-
COVID-19 status
Healthy
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
SOC, Vaccine
-
Trial Participants
1800
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
California
-
COVID-19 status
NA
-
Outcome
Mortality
-
Treatment
Plasma based therapy
-
Trial Participants
60
California
-
COVID-19 status
NA
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
Natural Killer Cells, SOC
-
Trial Participants
86
California
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other
-
Trial Participants
18
California
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
California
-
COVID-19 status
Confirmed
-
Outcome
Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
Stem cells
-
Trial Participants
9
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
California
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Visits or Returns to Emergency Department, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, D-Dimer, Troponin, Cardiac Outcome (Unspecified)
-
Treatment
Colchicine, SOC
-
Trial Participants
150
California
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Serious Adverse Events
-
Treatment
Anticoagulants, SOC
-
Trial Participants
600
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
mAb, SOC
-
Trial Participants
300
California
-
COVID-19 status
Confirmed
-
Outcome
ECG, SpO2
-
Treatment
Respiratory support
-
Trial Participants
50
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
208
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Viral Load or Clearance
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
500
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
California
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission
-
Treatment
ACEi, SOC
-
Trial Participants
560
California
-
COVID-19 status
Confirmed
-
Outcome
Fever
-
Treatment
Antiretroviral + Dexamethasone, Other, Other + Antiretroviral, Other + Dexamethasone
-
Trial Participants
525
California
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy
-
Trial Participants
30
California
-
COVID-19 status
Confirmed
-
Outcome
Platelet Count, ALT, AST, Albumin, Bilirubin, Glucose, Blood Urea Nitrogen
-
Treatment
HCQ + AZT, HCQ + AZT + LPV/r
-
Trial Participants
200
California
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
California
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
California
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance
-
Treatment
Hygiene
-
Trial Participants
150
California
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
mAb, SOC
-
Trial Participants
390
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, ECG, SpO2
-
Treatment
Other, SOC
-
Trial Participants
150
California
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Fever, Serious Adverse Events, Respiratory Rate, Radiographic Findings, Hypoxemia
-
Treatment
Other, SOC
-
Trial Participants
24
California
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
California
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Anticoagulants, SOC
-
Trial Participants
4000
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
479
California
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
380
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
60
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
California
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
NA
-
Trial Participants
200
California
-
COVID-19 status
Healthy
-
Outcome
IgG, IgM or IgA
-
Treatment
Vaccine
-
Trial Participants
175
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Hormone therapy, SOC
-
Trial Participants
198
California
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Adverse Events, C-Reactive Protein
-
Treatment
Other, SOC
-
Trial Participants
400
California
-
COVID-19 status
Confirmed
-
Outcome
Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate
-
Treatment
Non-invasive respiratory support
-
Trial Participants
30
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
120
California
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
California
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Fever, Adverse Events, Anti SARS-COV-2 Titers
-
Treatment
Hygiene
-
Trial Participants
45
California
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Plasma-based therapy, SOC
-
Trial Participants
96
California
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
40
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation
-
Treatment
mAb, SOC
-
Trial Participants
17
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
50
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
California
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
California
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
20
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
46
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
410
California
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin
-
Treatment
mAb, SOC
-
Trial Participants
270
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Serious Adverse Events
-
Treatment
Stem cells
-
Trial Participants
20
California
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Treatment-emergent Adverse Events, Serious Adverse Events, Antibodies
-
Treatment
mAb, SOC
-
Trial Participants
50
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Icatibant + Remdesivir, Other + Remdesivir, PDE4 inhibitor + Remdesivir, Remdesivir, VE-PTP inhibitor + Remdesivir
-
Trial Participants
1500
California
-
COVID-19 status
Confirmed
-
Outcome
Antibodies
-
Treatment
Other, SOC
-
Trial Participants
120
California
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings
-
Treatment
mAb, SOC
-
Trial Participants
86
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH
-
Treatment
Colchicine, SOC
-
Trial Participants
6000
California
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Treatment-emergent Adverse Events, IgG, IgM or IgA
-
Treatment
Other
-
Trial Participants
60
California
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6
-
Treatment
Other, SOC
-
Trial Participants
100
Callao
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Callao
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Cambridgeshire
-
COVID-19 status
Healthy
-
Outcome
Mortality
-
Treatment
HCQ, SOC
-
Trial Participants
1500
Cambridgeshire
-
COVID-19 status
Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Renal Outcome (Unspecified)
-
Treatment
JAKi, mAb, SOC
-
Trial Participants
1167
Cambridgeshire
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, IL-6, Lymphocyte Count, D-Dimer, LDH, Renal Outcome (Unspecified)
-
Treatment
Other, SGLT2 + Other, SOC
-
Trial Participants
1407
Canberra
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
2250
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Adverse Events
-
Treatment
Device
-
Trial Participants
20
Canberra
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, PaO2-FiO2
-
Treatment
SOC, Stem cells
-
Trial Participants
40
Canberra
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
216
Canberra
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Immunomodulators, SOC
-
Trial Participants
1000
Canberra
-
COVID-19 status
NA
-
Outcome
Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2
-
Treatment
SOC, Zinc
-
Trial Participants
160
Canberra
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Other Mild Symptoms, Serious or Seconday Infections, Anti SARS-COV-2 Titers
-
Treatment
Immunomodulators, SOC
-
Trial Participants
1000
Canberra
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
NA
-
Treatment
Anticoagulants, SOC
-
Trial Participants
206
Canberra
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, TCZ
-
Trial Participants
150
Canberra
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Fever, Treatment-emergent Adverse Events, Blood Gas, PaO2-FiO2
-
Treatment
SOC, Stem cells
-
Trial Participants
24
Canberra
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Depression, Anxiety
-
Treatment
Psychological therapy + Nutrition + Exercise
-
Trial Participants
40
Canberra
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
3468
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
682
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
230
Canberra
-
COVID-19 status
NA
-
Outcome
Other Mild Symptoms
-
Treatment
Other
-
Trial Participants
100
Canberra
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
Hygiene
-
Trial Participants
20
Canberra
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Secondary CoViD-19 Re-infection, Invasive Mechanical Ventilation or ECMO, Other Mild Symptoms, Adverse Events, Anti SARS-COV-2 Titers
-
Treatment
Stem cells
-
Trial Participants
24
Canberra
-
COVID-19 status
Confirmed
-
Outcome
SpO2
-
Treatment
Positioning, SOC
-
Trial Participants
20
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Adverse Events, Blood Pressure, Radiographic Findings
-
Treatment
ARBs, SOC
-
Trial Participants
36
Canberra
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
1419
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Canberra
-
COVID-19 status
Healthy
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
HCQ
-
Trial Participants
680
Canberra
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + HCQ
-
Trial Participants
2500
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation
-
Treatment
HCQ + LPV/r, HCQ + LPV/r + Plasma based therapy, LPV/r, LPV/r + Plasma based therapy, Plasma based therapy, SOC
-
Trial Participants
2400
Canberra
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Blood Gas, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
160
Canberra
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality
-
Treatment
HCQ, SOC
-
Trial Participants
400
Canberra
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
12
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Serious Adverse Events
-
Treatment
Other + Alternative therapy
-
Trial Participants
30
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + Zinc + Vitamins + AZT
-
Trial Participants
200
Canberra
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
FPV, SOC
-
Trial Participants
190
Canberra
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Cantabria
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Colchicine, SOC
-
Trial Participants
954
Cantabria
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Catania
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings
-
Treatment
TCZ
-
Trial Participants
400
Catania
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Anticoagulants
-
Trial Participants
300
Catanzaro
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Alternative therapy, SOC
-
Trial Participants
120
Catanzaro
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Lymphocyte Count
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
400
Ceara
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Celje
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, HCQ + Other
-
Trial Participants
90
Chandigarh
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)
-
Treatment
Other, SOC
-
Trial Participants
40
Chandigarh
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
325
Chandigarh
-
COVID-19 status
NA
-
Outcome
Serious or Seconday Infections, Adverse Events, Serious Adverse Events
-
Treatment
Other
-
Trial Participants
4000
Chandigarh
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Other Mild Symptoms, Adverse Events, Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
480
Chelyabinsk
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Cher
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, CK-MB, Procalcitonin, Radiographic Findings
-
Treatment
HCQ, SOC
-
Trial Participants
259
Chhattisgarh
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)
-
Treatment
Other, SOC
-
Trial Participants
40
Chiba
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Chiba
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
ARBs, SOC
-
Trial Participants
1372
Chieti
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Chieti
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
182
Chisinau
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Chisinau
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Chisinau
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
222
Chongqing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
Antivirals + IFN, Antivirals + LPV/r + IFN, LPV/r + IFN
-
Trial Participants
108
Chongqing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO
-
Treatment
Corticosteroids, SOC
-
Trial Participants
48
Chongqing
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, SpO2
-
Treatment
Other, SOC
-
Trial Participants
368
Chongqing
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
50
Chongqing
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Pneumonia or ARDS, Adverse Events, Treatment-emergent Adverse Events
-
Treatment
Natural Killer Cells
-
Trial Participants
90
Chongqing
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
IFN + Other, LPV/r + IFN, Umifenovir + IFN
-
Trial Participants
60
City
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
City
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
City
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
City
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Ciudad De Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Ciudad De Buenos Aires
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Troponin, LDH, Urine Sample
-
Treatment
Antihypertensive, SOC
-
Trial Participants
400
Ciudad De Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Ciudad De Buenos Aires
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events, Antibodies
-
Treatment
Ivermectin, SOC
-
Trial Participants
45
Ciudad Real
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG
-
Treatment
Other
-
Trial Participants
46
Ciudad Real
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
702
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Colorado
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1000
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Colorado
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2, Patient Positioning
-
Treatment
Positioning
-
Trial Participants
100
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
40
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Quality of Life
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
600
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Colorado
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Anticoagulants, SOC
-
Trial Participants
4000
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
479
Colorado
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, Quality of Life, Renal Outcome (Unspecified)
-
Treatment
Dexamethasone, SOC
-
Trial Participants
90
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Colorado
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, Blood Pressure, Renal Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
100
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Hemoglobin, Creatinine Phosphokinase, Prothrombin, ALT, Bilirubin, Glucose
-
Treatment
JAKi
-
Trial Participants
80
Colorado
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)
-
Treatment
NA
-
Trial Participants
80
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Colorado
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
10
Colorado
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Icatibant + Remdesivir, Other + Remdesivir, PDE4 inhibitor + Remdesivir, Remdesivir, VE-PTP inhibitor + Remdesivir
-
Trial Participants
1500
Conakry
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, SpO2
-
Treatment
Other, SOC
-
Trial Participants
142
Connecticut
-
COVID-19 status
NA
-
Outcome
Mortality, Viral Load or Clearance, Antibodies
-
Treatment
Plasma based therapy
-
Trial Participants
48
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
D-Dimer
-
Treatment
Other, SOC
-
Trial Participants
200
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Adverse Events
-
Treatment
DHODH inhibitor, SOC
-
Trial Participants
24
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
60
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Connecticut
-
COVID-19 status
NA
-
Outcome
Hospitalization
-
Treatment
Other, SOC
-
Trial Participants
60
Connecticut
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Connecticut
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
300
Connecticut
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Nutrition, SOC
-
Trial Participants
1500
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Icatibant + Remdesivir, Other + Remdesivir, PDE4 inhibitor + Remdesivir, Remdesivir, VE-PTP inhibitor + Remdesivir
-
Trial Participants
1500
Connecticut
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Other Mild Symptoms
-
Treatment
Other, SOC
-
Trial Participants
114
Connecticut
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings
-
Treatment
mAb, SOC
-
Trial Participants
86
Connecticut
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6
-
Treatment
Other, SOC
-
Trial Participants
100
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Quality of Life
-
Treatment
Corticosteroids, SOC
-
Trial Participants
1000
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Visits or Returns to Emergency Department, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH, Quality of Life
-
Treatment
AZT, HCQ, SOC
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein
-
Treatment
Sarilumab, TCZ
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Shock, Quality of Life, Renal Outcome (Unspecified)
-
Treatment
Corticosteroids, SOC
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)
-
Treatment
Remdesivir, SOC
-
Trial Participants
440
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life
-
Treatment
SOC, TCZ
-
Trial Participants
450
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Fever, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
NA
-
Trial Participants
350
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein
-
Treatment
Sarilumab, SOC, TCZ
-
Trial Participants
20
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge
-
Treatment
Other, SOC
-
Trial Participants
120
Copenhagen
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Viral Load or Clearance, Labor Absenteeism, Fever, Other Mild Symptoms
-
Treatment
SOC, Vaccine
-
Trial Participants
1500
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Respiratory support, SOC
-
Trial Participants
400
Copenhagen
-
COVID-19 status
NA
-
Outcome
Mortality, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Coagulation Test, Bilirubin, PaO2-FiO2, Renal Outcome (Unspecified)
-
Treatment
Other
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
HCQ, JAKi, Sarilumab, SOC
-
Trial Participants
1500
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
80
Copenhagen
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Antibodies
-
Treatment
NA
-
Trial Participants
6000
Copenhagen
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
1100
Copenhagen
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)
-
Treatment
Positioning
-
Trial Participants
150
Copenhagen
-
COVID-19 status
NA
-
Outcome
Mortality
-
Treatment
JAKi
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department, Viral Load or Clearance
-
Treatment
HCQ, SOC
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, LDH
-
Treatment
Antihypertensive, SOC
-
Trial Participants
200
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Blood Gas, Blood pH
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
226
Copenhagen
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Labor Absenteeism, Fever
-
Treatment
SOC, Vaccine
-
Trial Participants
NA
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Non-invasive Ventilation
-
Treatment
Remdesivir, SOC
-
Trial Participants
400
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
580
Copenhagen
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, Vitamins
-
Trial Participants
100
Cordoba
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Cordoba
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Cordoba
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Dyspnea, Adverse Events
-
Treatment
SOC, Vitamins
-
Trial Participants
1008
Cornwall
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Corrientes
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Renal Outcome (Unspecified)
-
Treatment
Ivermectin, SOC
-
Trial Participants
500
Corrientes
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Cosenza
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Lymphocyte Count
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
400
Cosenza
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, Radiographic Findings
-
Treatment
TCZ
-
Trial Participants
400
Cremona
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Cremona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Cremona
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Anticoagulants
-
Trial Participants
300
Cross River
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any)
-
Treatment
Nutrition, SOC
-
Trial Participants
90
Cuenca
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Cumbria
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Cundinamarca
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, Troponin, Procalcitonin, LDH, PaO2-FiO2
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
236
Cundinamarca
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, IgG, IgM or IgA
-
Treatment
Plasma based therapy
-
Trial Participants
10
Cundinamarca
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), IL-6, Hemoglobin, D-Dimer, Procalcitonin, AST, Bilirubin, Antibodies, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
60
Cundinamarca
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, IgG, IgM or IgA
-
Treatment
HCQ + AZT, Plasma based therapy + HCQ + AZT
-
Trial Participants
92
Cundinamarca
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Cundinamarca
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Daegu
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Daegu
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Dagestan
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
mAb, SOC
-
Trial Participants
206
Dakar
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Organ Failure or Dysfunction (SOFA), Serious Adverse Events
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
186
Dakar
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
HCQ + AZT, Zinc
-
Trial Participants
384
Delaware
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein, IL-6
-
Treatment
Other, SOC
-
Trial Participants
64
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
140
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
50000
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)
-
Treatment
Other, SOC
-
Trial Participants
40
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, PaO2-FiO2
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
100
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Delhi
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy
-
Trial Participants
50
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
200
Delhi
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy
-
Trial Participants
40
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
40000
Delhi
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
400
Delhi
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Radiation therapy
-
Trial Participants
10
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
120
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Exercise + Alternative therapy, SOC
-
Trial Participants
452
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Alternative therapy, SOC
-
Trial Participants
300
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Delhi
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospital Discharge, Invasive Mechanical Ventilation or ECMO
-
Treatment
Positioning
-
Trial Participants
20
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Delhi
-
COVID-19 status
Healthy
-
Outcome
Antibodies
-
Treatment
Psychological therapy, SOC
-
Trial Participants
250
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
800
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy
-
Trial Participants
500
Delhi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy + Hygiene+ Exercise + Psychological therapy
-
Trial Participants
425
Delhi
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
ARBs, SOC
-
Trial Participants
605
Delhi
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
Non-invasive respiratory support
-
Trial Participants
100
Delhi
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
96
Delhi
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Viral Load or Clearance
-
Treatment
Alternative therapy, SOC
-
Trial Participants
61000
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, PaO2-FiO2
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
452
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
50
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, PaO2-FiO2
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
100
Delhi
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Alternative therapy, SOC
-
Trial Participants
100
Delhi
-
COVID-19 status
Suspected
-
Outcome
NA
-
Treatment
Alternative therapy
-
Trial Participants
10000
Devon
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Ivermectin + Antibiotics, SOC
-
Trial Participants
400
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Remdesivir, SOC
-
Trial Participants
60
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Antibiotics, SOC
-
Trial Participants
94
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Cough, Fever
-
Treatment
Ivermectin, Ivermectin + Antibiotics, SOC
-
Trial Participants
72
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Colchicine, SOC
-
Trial Participants
300
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings
-
Treatment
FPV, SOC
-
Trial Participants
50
Dhaka
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
20
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Adverse Events
-
Treatment
Razuprotafib, SOC
-
Trial Participants
180
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2
-
Treatment
mAb, SOC
-
Trial Participants
384
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
208
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Fever
-
Treatment
Antiretroviral + Dexamethasone, Other, Other + Antiretroviral, Other + Dexamethasone
-
Trial Participants
525
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
District Of Columbia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospitalization
-
Treatment
mAb, SOC
-
Trial Participants
376
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
District Of Columbia
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
46
District Of Columbia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
Distrito Federal
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2
-
Treatment
HCQ, SOC
-
Trial Participants
630
Distrito Federal
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Dexamethasone, SOC
-
Trial Participants
299
Distrito Federal
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
440
Distrito Federal
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
Djibouti
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Dodoma
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Doha
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
NA
-
Treatment
Vasodilators
-
Trial Participants
40
Doha
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
500
Doha
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
456
Doha
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Doha
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Device, SOC
-
Trial Participants
20
Doha
-
COVID-19 status
Confirmed
-
Outcome
PaO2-FiO2, Renal Outcome (Unspecified)
-
Treatment
Anticoagulants, SOC
-
Trial Participants
100
Doha
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Dublin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Non-invasive Ventilation, C-Reactive Protein, Ferritin, IL-6, D-Dimer, LDH, Radiographic Findings, Shock
-
Treatment
SOC, TCZ
-
Trial Participants
90
Dublin
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Dublin
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, IL-1, IL-6, IL-8, IL-10, Tumor Necrosis Factor (Any), PaO2-FiO2, Shock, Renal Outcome (Unspecified)
-
Treatment
Other
-
Trial Participants
36
Dublin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, PaO2-FiO2
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
267
Dublin
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Dublin
-
COVID-19 status
NA
-
Outcome
Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Respiratory Rate, Patient Positioning
-
Treatment
Positioning, SOC
-
Trial Participants
200
Dublin
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Serious Adverse Events, SpO2
-
Treatment
Other, SOC
-
Trial Participants
90
Dudley
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
150
Dudley
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Dundee
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Pneumonia or ARDS
-
Treatment
AZT, SOC
-
Trial Participants
800
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
30
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Alternative therapy, SOC
-
Trial Participants
80
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
Organ Failure or Dysfunction (SOFA), Platelet Count, Coagulation Test, Bilirubin, PaO2-FiO2, Renal Outcome (Unspecified)
-
Treatment
HCQ, HCQ + Raltagravir, HCQ + Raltagravir + IFN
-
Trial Participants
60
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
SOC, Vitamins
-
Trial Participants
30
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein, White Blood Cell Count, Respiratory Rate
-
Treatment
NA
-
Trial Participants
60
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
200
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
Alternative therapy, SOC
-
Trial Participants
86
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events, ALT
-
Treatment
Alternative therapy, SOC
-
Trial Participants
110
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
60
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Radiographic Findings
-
Treatment
HCQ + LPV/r + Antivirals, Igs + HCQ + LPV/r + Antivirals
-
Trial Participants
100
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Radiographic Findings
-
Treatment
Dialysis
-
Trial Participants
10
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Plasma based therapy
-
Trial Participants
30
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
HCQ + LPV/r, HCQ + LPV/r + Other
-
Trial Participants
60
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance
-
Treatment
HCQ, SOC
-
Trial Participants
500
East Azarbaijan
-
COVID-19 status
NA
-
Outcome
Fever, Other Mild Symptoms, C-Reactive Protein, Blood Pressure, Heart Rate, Respiratory Rate, Radiographic Findings
-
Treatment
Alternative therapy, SOC
-
Trial Participants
10
East Azarbaijan
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
300
East Azarbaijan
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein
-
Treatment
Other, SOC
-
Trial Participants
40
East Azarbaijan
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, White Blood Cell Count, SpO2, Respiratory Rate, Radiographic Findings
-
Treatment
Alternative therapy, SOC
-
Trial Participants
80
East Sussex
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Edinburgh
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Non-invasive Ventilation
-
Treatment
Other, SOC
-
Trial Participants
389
Edinburgh
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Edinburgh
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Viral Load or Clearance, Adverse Events, Coagulation Test, SpO2, Renal Outcome (Unspecified)
-
Treatment
Anticoagulants, Other, SOC
-
Trial Participants
60
Edinburgh
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Espirito Santo
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
440
Espirito Santo
-
COVID-19 status
Confirmed
-
Outcome
Mortality, D-Dimer, Troponin
-
Treatment
Anticoagulants
-
Trial Participants
600
Essex
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Fars
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Respiratory Rate
-
Treatment
NA
-
Trial Participants
374
Fars
-
COVID-19 status
Suspected
-
Outcome
Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein
-
Treatment
Alternative therapy, SOC
-
Trial Participants
60
Fars
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
Corticosteroids + Igs + IFN, HCQ + Antivirals
-
Trial Participants
105
Fars
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Vaccine
-
Trial Participants
130000
Fars
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Fever, SpO2
-
Treatment
Alternative therapy, SOC
-
Trial Participants
60
Firenze
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Florida
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Treatment-emergent Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
436
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Other, SOC
-
Trial Participants
40
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
702
Florida
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation, Treatment-emergent Adverse Events, Serious Adverse Events, Lymphocyte Count, Antibodies
-
Treatment
CD122-preferential IL2 pathway, SOC
-
Trial Participants
30
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, D-Dimer, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
20
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8
-
Treatment
Other, SOC
-
Trial Participants
48
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
Florida
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Fever, Organ Failure or Dysfunction (SOFA), SpO2, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
252
Florida
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, Antibodies
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
24
Florida
-
COVID-19 status
NA
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, D-Dimer, Troponin, Antibodies
-
Treatment
SOC, Stem cells
-
Trial Participants
24
Florida
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Dyspnea, Organ Failure or Dysfunction (SOFA), PaO2-FiO2
-
Treatment
ARBs
-
Trial Participants
200
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Florida
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
DHODH inhibitor, SOC
-
Trial Participants
100
Florida
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
SOC, Vitamins, Vitamins + Zinc, Zinc
-
Trial Participants
520
Florida
-
COVID-19 status
NA
-
Outcome
Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Dyspnea, PaO2-FiO2, 6-Minute Walking Distance
-
Treatment
Inhaled solution, SOC
-
Trial Participants
288
Florida
-
COVID-19 status
Healthy
-
Outcome
Mortality, Serious Adverse Events, Interferon (Any), Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
6578
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8
-
Treatment
Other, SOC
-
Trial Participants
48
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia
-
Treatment
Inhaled solution, SOC
-
Trial Participants
144
Florida
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2
-
Treatment
Merimepodib + Remdesivir, Remdesivir
-
Trial Participants
80
Florida
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Florida
-
COVID-19 status
Suspected
-
Outcome
NA
-
Treatment
Antivirals + Vitamins, Vitamins
-
Trial Participants
800
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, SpO2
-
Treatment
Alternative therapy, SOC
-
Trial Participants
280
Florida
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, Vitamins
-
Trial Participants
160
Florida
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission
-
Treatment
SOC, Stem cells
-
Trial Participants
70
Florida
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Serious Adverse Events
-
Treatment
Anticoagulants, SOC
-
Trial Participants
600
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Adverse Events
-
Treatment
DHODH inhibitor, SOC
-
Trial Participants
24
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
mAb, SOC
-
Trial Participants
300
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Viral Load or Clearance
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
500
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Pneumonia or ARDS, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Electrolytes, LDH
-
Treatment
SOC, Stem cells
-
Trial Participants
21
Florida
-
COVID-19 status
Confirmed
-
Outcome
Fever, Serious Adverse Events, Platelet Count, ALT, AST, Albumin, Bilirubin, Blood Pressure, Heart Rate, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
Florida
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
100
Florida
-
COVID-19 status
Confirmed
-
Outcome
Fever
-
Treatment
Antiretroviral + Dexamethasone, Other, Other + Antiretroviral, Other + Dexamethasone
-
Trial Participants
525
Florida
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality
-
Treatment
SOC, Vaccine
-
Trial Participants
96
Florida
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Florida
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
mAb, SOC
-
Trial Participants
390
Florida
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Fever, Serious Adverse Events, Respiratory Rate, Radiographic Findings, Hypoxemia
-
Treatment
Other, SOC
-
Trial Participants
24
Florida
-
COVID-19 status
NA
-
Outcome
IL-6, Glucose, SpO2
-
Treatment
DPP-4i, SOC
-
Trial Participants
20
Florida
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Florida
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Anticoagulants, SOC
-
Trial Participants
4000
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
479
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Hormone therapy, SOC
-
Trial Participants
198
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin, LDH
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Florida
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Florida
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
300
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Florida
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
Florida
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
260
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
46
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
410
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Florida
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Adverse Events
-
Treatment
Antirheumatic, SOC
-
Trial Participants
1000
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin
-
Treatment
mAb, SOC
-
Trial Participants
270
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
mAb, SOC
-
Trial Participants
124
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
Florida
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
FPV, SOC
-
Trial Participants
50
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH
-
Treatment
Colchicine, SOC
-
Trial Participants
6000
Florida
-
COVID-19 status
NA
-
Outcome
Hospitalization
-
Treatment
Anticoagulants, Antihypertensive, SOC
-
Trial Participants
7000
Florida
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Lymphocyte Count, D-Dimer
-
Treatment
Immunomodulators, SOC
-
Trial Participants
243
Foggia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Anticoagulants
-
Trial Participants
300
Fujian
-
COVID-19 status
Resolved
-
Outcome
Quality of Life
-
Treatment
Respiratory support
-
Trial Participants
80
Fujian
-
COVID-19 status
Confirmed
-
Outcome
IL-6, Quality of Life, Distress
-
Treatment
Respiratory support, SOC
-
Trial Participants
80
Fujian
-
COVID-19 status
Healthy
-
Outcome
Quality of Life
-
Treatment
Respiratory support, SOC
-
Trial Participants
80
Fujian
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Serious Adverse Events, Heart Rate, Respiratory Rate
-
Treatment
HCQ, SOC
-
Trial Participants
100
Fujian
-
COVID-19 status
NA
-
Outcome
C-Reactive Protein, IL-10, Tumor Necrosis Factor (Any), CD4, CD8, Blood Gas, PaO2-FiO2
-
Treatment
Oseltamivir + Non-invasive respiratory support + Hormone therapy, Stem cells + Oseltamivir + Non-invasive respiratory support + Hormone therapy
-
Trial Participants
60
Fujian
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Viral Load or Clearance, Fever, Serious Adverse Events, Respiratory Rate
-
Treatment
HCQ, SOC
-
Trial Participants
100
Fukuoka
-
COVID-19 status
NA
-
Outcome
Serious Adverse Events
-
Treatment
Vaccine
-
Trial Participants
256
Galway
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Troponin
-
Treatment
Antihypertensive
-
Trial Participants
2414
Gauteng
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Gauteng
-
COVID-19 status
NA
-
Outcome
Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
2130
Gauteng
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Gauteng
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Gauteng
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
40
Gaziantep
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Other, SOC
-
Trial Participants
200
Gaziantep
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Gelderland
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Labor Absenteeism, Fever, Other Mild Symptoms, Anti SARS-COV-2 Titers, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
1500
Gelderland
-
COVID-19 status
Resolved
-
Outcome
Other Mild Symptoms, 6-Minute Walking Distance
-
Treatment
Rehabilitation
-
Trial Participants
40
Georgia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir + Dexamethasone, Remdesivir + JAKi
-
Trial Participants
1500
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, Fibrinogen, INR, Albumin, Bilirubin, Blood Urea Nitrogen, Blood Pressure, Heart Rate, Respiratory Rate
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
20
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
702
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, CD8
-
Treatment
Vaccine
-
Trial Participants
32
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Georgia
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance
-
Treatment
DHODH inhibitor, SOC
-
Trial Participants
100
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate, Blood pH, Bicarbonates
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
2
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
24
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Georgia
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
mAb, SOC
-
Trial Participants
300
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Fever, Serious Adverse Events, Platelet Count, ALT, AST, Albumin, Bilirubin, Blood Pressure, Heart Rate, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Georgia
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
mAb, SOC
-
Trial Participants
390
Georgia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Fever, Serious Adverse Events, Respiratory Rate, Radiographic Findings, Hypoxemia
-
Treatment
Other, SOC
-
Trial Participants
24
Georgia
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Anticoagulants, SOC
-
Trial Participants
4000
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
380
Georgia
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospitalization
-
Treatment
mAb, SOC
-
Trial Participants
376
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Blood Gas, Blood Pressure, Heart Rate, SpO2, Respiratory Rate
-
Treatment
Non-invasive respiratory support
-
Trial Participants
30
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin, LDH
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Georgia
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
mAb, SOC
-
Trial Participants
124
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Georgia
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin
-
Treatment
mAb, SOC
-
Trial Participants
270
Georgia
-
COVID-19 status
NA
-
Outcome
C-Reactive Protein, Ferritin, IL-6, Hemoglobin, D-Dimer, eGFR, Myoglobin, Troponin, Procalcitonin, Fibrinogen, Triglycerides, ALT, AST, Albumin, Bilirubin, LDH, Blood Gas, Blood Pressure, Heart Rate, Radiographic Findings, Blood pH
-
Treatment
Radiation therapy
-
Trial Participants
10
Georgia
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization
-
Treatment
HCQ, SOC
-
Trial Participants
700
Georgia
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Natural Killer Cell Count, CD4, CD8, SpO2, Radiographic Findings
-
Treatment
mAb, SOC
-
Trial Participants
86
Gerona
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Gibraltar
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), C-Reactive Protein, Troponin
-
Treatment
Colchicine, SOC
-
Trial Participants
180
Glasgow
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Glasgow
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Goias
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Goias
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
440
Golestan
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
NA
-
Trial Participants
45
Golestan
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
60
Golestan
-
COVID-19 status
Confirmed
-
Outcome
Platelet Count, Radiographic Findings
-
Treatment
Alternative therapy, SOC
-
Trial Participants
50
Granada
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
TCZ
-
Trial Participants
500
Granada
-
COVID-19 status
NA
-
Outcome
ICU Admission, Pneumonia or ARDS, Cough, Other Mild Symptoms
-
Treatment
Nutrition, SOC
-
Trial Participants
314
Granada
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Granada
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Greater Accra
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Greenwich
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Groningen
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission
-
Treatment
Plasma-based therapy
-
Trial Participants
690
Groningen
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Antibodies, PaO2-FiO2
-
Treatment
HCQ, SOC
-
Trial Participants
8
Groningen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
426
Guadalajara
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Creatinine Phosphokinase, ALT, AST, Bilirubin, ECG
-
Treatment
Other
-
Trial Participants
46
Guam
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, ALT, Albumin, Bilirubin, Quality of Life
-
Treatment
Non-invasive respiratory support
-
Trial Participants
440
Guangdong
-
COVID-19 status
NA
-
Outcome
Mortality, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Adverse Events, C-Reactive Protein, CD4, CD8, PaO2-FiO2, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
20
Guangdong
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Fever, C-Reactive Protein, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Procalcitonin, ALT, Albumin, Bilirubin, Blood Gas, Radiographic Findings, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
TCM
-
Trial Participants
72
Guangdong
-
COVID-19 status
NA
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, Dyspnea, C-Reactive Protein, White Blood Cell Count, CD4, CD8, Renal Outcome (Unspecified)
-
Treatment
NA
-
Trial Participants
300
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein, IL-17, Lymphocyte Count, Blood Gas
-
Treatment
SOC, Vaccine
-
Trial Participants
120
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, C-Reactive Protein, White Blood Cell Count, Neutrophils, Hemoglobin, Urine Sample, IgG, IgM or IgA, Blood Urea Nitrogen
-
Treatment
NA
-
Trial Participants
100
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
NA
-
Trial Participants
60
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Organ Failure or Dysfunction (SOFA), Quality of Life
-
Treatment
Nutrition, SOC
-
Trial Participants
80
Guangdong
-
COVID-19 status
Resolved
-
Outcome
Dyspnea, Weight, Height or BMI
-
Treatment
Other, TCM + Other
-
Trial Participants
150
Guangdong
-
COVID-19 status
Resolved
-
Outcome
Other Mild Symptoms
-
Treatment
SOC, TCM
-
Trial Participants
144
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, White Blood Cell Count, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, ALT, Albumin, Bilirubin, IgG, IgM or IgA, PaO2-FiO2, Respiratory Rate, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
400
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Pneumonia or ARDS, Treatment-emergent Adverse Events
-
Treatment
SOC, TCM
-
Trial Participants
204
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, White Blood Cell Count, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, Troponin, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, ALT, Albumin, Bilirubin, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
300
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Hygiene, SOC
-
Trial Participants
40
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Radiographic Findings
-
Treatment
Vaccine
-
Trial Participants
100
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Anticoagulants, Other
-
Trial Participants
120
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Pneumonia or ARDS, ALT
-
Treatment
IFN + Other, Umifenovir + IFN
-
Trial Participants
30
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Erythrocyte Sedimentation Rate
-
Treatment
SOC, TCM
-
Trial Participants
120
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Cough, C-Reactive Protein
-
Treatment
SOC, TCM
-
Trial Participants
128
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Treatment-emergent Adverse Events, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
40
Guangdong
-
COVID-19 status
Resolved
-
Outcome
Clinical Improvement Score (Any), 6-Minute Walking Distance, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
120
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Cough, Dyspnea, SpO2, Distress
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
90
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Respiratory Rate
-
Treatment
Anticoagulants, SOC
-
Trial Participants
60
Guangdong
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, C-Reactive Protein
-
Treatment
Vaccine
-
Trial Participants
100
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Serious or Seconday Infections, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
SOC, TCM + Umifenovir
-
Trial Participants
40
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), C-Reactive Protein, Erythrocyte Sedimentation Rate
-
Treatment
Nutrition, SOC
-
Trial Participants
394
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, Tumor Necrosis Factor (Any), Interferon (Any), Creatinine Phosphokinase, CK-MB, eGFR, Myoglobin, ALT, Bilirubin, Blood Pressure, Heart Rate, PaO2-FiO2, Respiratory Rate, Radiographic Findings
-
Treatment
LPV/r, SOC, Umifenovir
-
Trial Participants
86
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
200
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS, C-Reactive Protein, IL-2, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Lymphocyte Count, Erythrocyte Sedimentation Rate, D-Dimer, Myoglobin, Procalcitonin, Electrolytes, Glucose, Blood Gas, Renal Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
60
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
DAA, FPV
-
Trial Participants
30
Guangdong
-
COVID-19 status
Healthy
-
Outcome
Household Members with CoViD-19
-
Treatment
SOC, TCM
-
Trial Participants
828
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
SpO2
-
Treatment
Non-invasive respiratory support
-
Trial Participants
198
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, C-Reactive Protein, IL-6, IL-10, Tumor Necrosis Factor (Any), Lymphocyte Count, Neutrophils, Platelet Count, D-Dimer, Myoglobin, Procalcitonin, Prothrombin, Fibrinogen, Coagulation Test, Renal Outcome (Unspecified)
-
Treatment
HCQ, LPV/r
-
Trial Participants
112
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance
-
Treatment
HCQ, LPV/r, LPV/r + HCQ
-
Trial Participants
205
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein
-
Treatment
HCQ, SOC
-
Trial Participants
20
Guangdong
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
FPV + IFN, IFN, LPV/r + IFN
-
Trial Participants
90
Guangxi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
SOC, Vaccine
-
Trial Participants
60
Guayas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Guizhou
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, PaO2-FiO2, Respiratory Rate
-
Treatment
Respiratory support
-
Trial Participants
200
Guizhou
-
COVID-19 status
Confirmed
-
Outcome
CK-MB, LDH
-
Treatment
Other
-
Trial Participants
200
Gujarat
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
Alternative therapy, SOC
-
Trial Participants
200
Gujarat
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Gujarat
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Gujarat
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
48
Gujarat
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)
-
Treatment
Other, SOC
-
Trial Participants
106
Gunma
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, C-Reactive Protein
-
Treatment
FPV
-
Trial Participants
100
Gunma
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, C-Reactive Protein
-
Treatment
HCQ + LPV/r, Oseltamivir + HCQ + LPV/r
-
Trial Participants
50
Gyeonggi
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Device, Vaccine + Device
-
Trial Participants
160
Gyeonggi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Gyeonggi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Gyeonggi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Haifa
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
582
Haifa
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
Haifa
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2
-
Treatment
Other, SOC
-
Trial Participants
50
Haifa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
Antihypertensive, SOC
-
Trial Participants
120
Hamadan
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Other, SOC
-
Trial Participants
92
Hamadan
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Corticosteroids, Dexamethasone
-
Trial Participants
81
Hamburg
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, IL-10, Tumor Necrosis Factor (Any), Procalcitonin, Bicarbonates, Renal Outcome (Unspecified)
-
Treatment
Cytokine removal, SOC
-
Trial Participants
24
Hamburg
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Hamburg
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, LDH
-
Treatment
Antihypertensive, SOC
-
Trial Participants
200
Hamburg
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Anticoagulants
-
Trial Participants
172
Hamburg
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Hamburg
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Hamburg
-
COVID-19 status
NA
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
220
Hampshire
-
COVID-19 status
Confirmed, Suspected Or Healthy
-
Outcome
Viral Load or Clearance
-
Treatment
Hygiene, SOC
-
Trial Participants
40
Hanoi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
250
Hanoi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
44
Hanoi
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
10
Harare
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Haryana
-
COVID-19 status
Healthy
-
Outcome
Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
25800
Haryana
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
SOC, TCZ
-
Trial Participants
180
Haryana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Haryana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Haryana
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge
-
Treatment
Alternative therapy, SOC
-
Trial Participants
60
Havana
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Adverse Events, Serious Adverse Events, C-Reactive Protein, IL-6, Tumor Necrosis Factor (Any), Interferon (Any), Prothrombin, Triglycerides, ALT, Albumin, Bilirubin, Glucose
-
Treatment
SOC, Vaccine
-
Trial Participants
80
Havana
-
COVID-19 status
Confirmed
-
Outcome
Labor Absenteeism
-
Treatment
IFN
-
Trial Participants
120
Havana
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
IFN
-
Trial Participants
30
Havana
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
mAb
-
Trial Participants
80
Havana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge
-
Treatment
Other
-
Trial Participants
16
Havana
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
115000
Havana
-
COVID-19 status
Healthy
-
Outcome
Monocyte Count, Lymphocyte Count, Dendritic Cell Count, CD4, CD8
-
Treatment
Other
-
Trial Participants
60
Havana
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
20
Havana
-
COVID-19 status
Confirmed
-
Outcome
Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
HCQ + Antivirals + Inferon, Other + HCQ + Antivirals + Inferon
-
Trial Participants
32
Havana
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Immunomodulators
-
Trial Participants
NA
Havana
-
COVID-19 status
Resolved
-
Outcome
Pneumonia or ARDS
-
Treatment
Corticosteroids, Stem cells
-
Trial Participants
20
Hawaii
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Hawaii
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
208
Hawaii
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Hawaii
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Hawaii
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Hawaii
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Hawaii
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO
-
Treatment
SOC, TCZ
-
Trial Participants
300
Hawaii
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Heart Rate
-
Treatment
HCQ, SOC
-
Trial Participants
17
Hebei
-
COVID-19 status
Suspected
-
Outcome
Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
240
Hebei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
240
Hebei
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Fever, Respiratory Rate
-
Treatment
SOC, TCM
-
Trial Participants
110
Hebei
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Treatment-emergent Adverse Events, Respiratory Rate
-
Treatment
IFN, SOC
-
Trial Participants
328
Heilongjiang
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, Urine Sample, Blood Pressure, ECG, Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
240
Heilongjiang
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
30
Heilongjiang
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Cough, Fever, SpO2, Respiratory Rate, 6-Minute Walking Distance, Radiographic Findings, Quality of Life, Depression, Anxiety
-
Treatment
Respiratory support, SOC
-
Trial Participants
60
Heilongjiang
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Fever, Radiographic Findings, Lung Inflamation
-
Treatment
Other, SOC
-
Trial Participants
240
Heilongjiang
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Hospital Discharge, C-Reactive Protein, White Blood Cell Count, Coagulation Test, IgG, IgM or IgA, Antibodies
-
Treatment
Other, SOC
-
Trial Participants
350
Helsinki
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)
-
Treatment
SOC, TCZ
-
Trial Participants
90
Helsinki
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
HCQ, Remdesivir, SOC
-
Trial Participants
NA
Henan
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Radiographic Findings, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
100
Henan
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Treatment-emergent Adverse Events, CD4, CD8, Radiographic Findings
-
Treatment
Natural Killer Cells, SOC
-
Trial Participants
30
Henan
-
COVID-19 status
Resolved
-
Outcome
Anxiety
-
Treatment
SOC, TCM
-
Trial Participants
28
Henan
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Radiographic Findings
-
Treatment
TCM
-
Trial Participants
24
Henan
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein, IL-1, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, IP-10, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Procalcitonin, ALT, Albumin, Bilirubin, Glucose, Urine Sample, Radiographic Findings, Depression, Anxiety, Distress
-
Treatment
Stem cells
-
Trial Participants
20
Henan
-
COVID-19 status
Confirmed
-
Outcome
Depression, Anxiety
-
Treatment
Psychological therapy
-
Trial Participants
81
Henan
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Fever, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
30
Henan
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, CD4, CD8
-
Treatment
DAA
-
Trial Participants
10
Henan
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, CD4, CD8
-
Treatment
DAA
-
Trial Participants
30
Henan
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
288
Henan
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms, CD4, Radiographic Findings
-
Treatment
Antivirals, SOC
-
Trial Participants
20
Henan
-
COVID-19 status
Resolved
-
Outcome
Visits or Returns to Emergency Department, Pneumonia or ARDS, Radiographic Findings, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
100
Henan
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Pneumonia or ARDS, Fever
-
Treatment
SOC, TCM
-
Trial Participants
60
Hertfordshire
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Hessen
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Coagulation Test
-
Treatment
Anticoagulants, SOC
-
Trial Participants
400
Ho Chi Minh City
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Fever, Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
250
Hong Kong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events, IL-6, Tumor Necrosis Factor (Any)
-
Treatment
LPV/r, LPV/r + IFN
-
Trial Participants
127
Hong Kong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Adverse Events
-
Treatment
Antibiotics, IFN + Antibiotics, SOC
-
Trial Participants
81
Hong Kong
-
COVID-19 status
NA
-
Outcome
Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, IL-1, IL-2, IL-6, Tumor Necrosis Factor (Any)
-
Treatment
mAb, SOC
-
Trial Participants
15
Hong Kong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events
-
Treatment
HCQ, IFN
-
Trial Participants
60
Hong Kong
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Hong Kong
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Hubei
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, C-Reactive Protein, Radiographic Findings
-
Treatment
TCM
-
Trial Participants
300
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, CD4, CD8
-
Treatment
HCQ, SOC
-
Trial Participants
300
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, CD4, PaO2-FiO2, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
100
Hubei
-
COVID-19 status
Healthy
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever
-
Treatment
Education + Monitoring + TCM, Psychological therapy
-
Trial Participants
600
Hubei
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever
-
Treatment
Education, Education + TCM
-
Trial Participants
400
Hubei
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Blood Pressure, Heart Rate, Surfactant Factor Protein, PaO2-FiO2, Respiratory Rate, Radiographic Findings
-
Treatment
IFN, TCM
-
Trial Participants
238
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Radiographic Findings
-
Treatment
Corticosteroids, SOC
-
Trial Participants
100
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Radiographic Findings
-
Treatment
DRV/c + Other, LPV/r + Other, Other
-
Trial Participants
100
Hubei
-
COVID-19 status
Suspected Or Healthy
-
Outcome
Viral Load or Clearance, Fever, Weight, Height or BMI, Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Blood Pressure, Heart Rate, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
160
Hubei
-
COVID-19 status
Resolved
-
Outcome
Adverse Events, 6-Minute Walking Distance, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
100
Hubei
-
COVID-19 status
Resolved
-
Outcome
Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate, 6-Minute Walking Distance, Quality of Life
-
Treatment
Psychological therapy, SOC
-
Trial Participants
100
Hubei
-
COVID-19 status
Resolved
-
Outcome
Adverse Events, 6-Minute Walking Distance, Quality of Life
-
Treatment
Exercise, SOC
-
Trial Participants
100
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough, Fever, Adverse Events, 6-Minute Walking Distance, Quality of Life
-
Treatment
SOC, TCM
-
Trial Participants
100
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, C-Reactive Protein, Procalcitonin, CD4, CD8, PaO2-FiO2
-
Treatment
SOC, Stem cells
-
Trial Participants
48
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
FPV, FPV + TCZ, TCZ
-
Trial Participants
150
Hubei
-
COVID-19 status
NA
-
Outcome
Mortality, Viral Load or Clearance, Cough, Fever, Dyspnea, C-Reactive Protein, IL-1, IL-6, IL-8, Tumor Necrosis Factor (Any), Procalcitonin, CD4, CD8, SpO2, Radiographic Findings
-
Treatment
NA
-
Trial Participants
30
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings
-
Treatment
NA
-
Trial Participants
36
Hubei
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Cough, Fever, Dyspnea, Other Mild Symptoms, Adverse Events, Treatment-emergent Adverse Events
-
Treatment
IFN, IFN + Other
-
Trial Participants
2944
Hubei
-
COVID-19 status
Resolved
-
Outcome
Antibodies, 6-Minute Walking Distance, Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
Other, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
42
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, Neutrophils, Creatinine Phosphokinase, CK-MB, Troponin, Procalcitonin, ALT, LDH, CD4, CD8, Respiratory Rate, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
20
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS, Radiographic Findings, Quality of Life, Depression, Anxiety, Distress
-
Treatment
Stem cells
-
Trial Participants
20
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Organ Failure or Dysfunction (SOFA), Serious Adverse Events
-
Treatment
FPV, Umifenovir
-
Trial Participants
240
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Dyspnea, C-Reactive Protein, PaO2-FiO2, SpO2, Radiographic Findings
-
Treatment
mAb
-
Trial Participants
27
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Cough, Fever, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, PaO2-FiO2
-
Treatment
Alternative therapy, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, Organ Failure or Dysfunction (SOFA), Adverse Events, C-Reactive Protein, CK-MB, ALT, PaO2-FiO2, Radiographic Findings
-
Treatment
Other
-
Trial Participants
10
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Pneumonia or ARDS, C-Reactive Protein, Tumor Necrosis Factor (Any), Interferon (Any), Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
300
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Hypoxia
-
Treatment
Non-invasive respiratory support
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Creatinine Phosphokinase, CK-MB, ALT, Blood Urea Nitrogen
-
Treatment
SOC, TCM
-
Trial Participants
100
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
96
Hubei
-
COVID-19 status
Healthy
-
Outcome
Treatment-emergent Adverse Events, Serious Adverse Events, Antibodies
-
Treatment
Vaccine
-
Trial Participants
108
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Glucose, Radiographic Findings
-
Treatment
TCM
-
Trial Participants
50
Hubei
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
300
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Anti SARS-COV-2 Titers, PaO2-FiO2, Respiratory Rate, Radiographic Findings
-
Treatment
Igs, SOC
-
Trial Participants
10
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, Tumor Necrosis Factor (Any), Granulocyte Stimulaiting Factor, Erythrocyte Sedimentation Rate, Creatinine Phosphokinase, CK-MB, eGFR, Procalcitonin, ALT, Albumin, Bilirubin
-
Treatment
LPV/r, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Other Mild Symptoms, Stool Sample
-
Treatment
SOC, TCM
-
Trial Participants
200
Hubei
-
COVID-19 status
NA
-
Outcome
Viral Load or Clearance, Adverse Events, Serious Adverse Events, Anti SARS-COV-2 Titers, Interferon (Any), IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
508
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, IL-8, Tumor Necrosis Factor (Any), White Blood Cell Count, Shock
-
Treatment
SOC, TCM
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Dyspnea, Serious Adverse Events, Granulocyte Stimulaiting Factor, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Neutrophils, ALT, Albumin, Bilirubin, IgG, IgM or IgA
-
Treatment
Cyclosporine, HCQ, SOC
-
Trial Participants
80
Hubei
-
COVID-19 status
Resolved
-
Outcome
Clinical Improvement Score (Any), Fever, Antibodies, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
120
Hubei
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Viral Load or Clearance, Cough, Fever, Other Mild Symptoms
-
Treatment
SOC, TCM
-
Trial Participants
400
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Respiratory Rate
-
Treatment
Anticoagulants, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, TCM
-
Trial Participants
200
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events
-
Treatment
LPV/r, SOC
-
Trial Participants
160
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
SOC, Stem cells
-
Trial Participants
70
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Erythrocyte Sedimentation Rate, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
152
Hubei
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Corticosteroids, SOC
-
Trial Participants
86
Hubei
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance
-
Treatment
TCM
-
Trial Participants
100
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea, Serious Adverse Events, C-Reactive Protein, PaO2-FiO2, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
90
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Treatment-emergent Adverse Events
-
Treatment
IFN, SOC
-
Trial Participants
328
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, White Blood Cell Count, Lymphocyte Count, Neutrophils, Antibodies, Radiographic Findings
-
Treatment
TCM
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, Radiographic Findings, Renal Outcome (Unspecified)
-
Treatment
Corticosteroids, SOC
-
Trial Participants
200
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Procalcitonin, PaO2-FiO2, Radiographic Findings
-
Treatment
Stem cells
-
Trial Participants
16
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
SOC, TCM
-
Trial Participants
120
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Dyspnea, SpO2, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
340
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Cough, Dyspnea, IL-8
-
Treatment
Other, SOC
-
Trial Participants
292
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Cough, Fever, Dyspnea
-
Treatment
TCM
-
Trial Participants
40
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Cough, Fever, Dyspnea
-
Treatment
SOC, TCM
-
Trial Participants
40
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, PaO2-FiO2, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
294
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, Serious Adverse Events, IL-1, IL-6, Tumor Necrosis Factor (Any), Interferon (Any)
-
Treatment
TCZ
-
Trial Participants
60
Hubei
-
COVID-19 status
NA
-
Outcome
6-Minute Walking Distance, Radiographic Findings, Quality of Life
-
Treatment
Education, TCM + Education
-
Trial Participants
160
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation
-
Treatment
NA
-
Trial Participants
4
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, C-Reactive Protein, Natural Killer Cell Count, CD4, CD8
-
Treatment
IFN, SOC
-
Trial Participants
80
Hubei
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Cough, Fever, Serious Adverse Events, C-Reactive Protein, Radiographic Findings
-
Treatment
HCQ, Umifenovir
-
Trial Participants
320
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, C-Reactive Protein, Radiographic Findings
-
Treatment
DMARD, SOC
-
Trial Participants
200
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
NA
-
Trial Participants
40
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
100
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Fever, Radiographic Findings, Lung Inflamation
-
Treatment
Other, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
80
Hubei
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, TCM
-
Trial Participants
200
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Dyspnea, Other Mild Symptoms, Adverse Events, Serious Adverse Events
-
Treatment
SOC, TCM
-
Trial Participants
160
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Fever
-
Treatment
SOC, TCM
-
Trial Participants
160
Hubei
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Other Mild Symptoms, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
300
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Other, SOC
-
Trial Participants
40
Hubei
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
90
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
FPV, SOC
-
Trial Participants
210
Hubei
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Alternative therapy, SOC
-
Trial Participants
750
Hubei
-
COVID-19 status
NA
-
Outcome
Other Mild Symptoms
-
Treatment
SOC, TCM
-
Trial Participants
200
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
mAb, Other, SOC
-
Trial Participants
120
Hubei
-
COVID-19 status
NA
-
Outcome
Other Mild Symptoms
-
Treatment
SOC, TCM
-
Trial Participants
200
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Viral Load or Clearance
-
Treatment
Other, SOC
-
Trial Participants
60
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Organ Failure or Dysfunction (SOFA), Coagulation Test, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
160
Hubei
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Cough, Fever, Other Mild Symptoms
-
Treatment
Other
-
Trial Participants
40
Hubei
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Cough, Fever, Dyspnea, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Respiratory Rate
-
Treatment
LPV/r, SOC
-
Trial Participants
328
Hubei
-
COVID-19 status
Resolved
-
Outcome
Quality of Life, Depression, Anxiety
-
Treatment
Psychological therapy, TCM, TCM + Psychological therapy
-
Trial Participants
90
Huila
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
AZT, HCQ, LPV/r, SOC
-
Trial Participants
1200
Hunan
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Pneumonia or ARDS, PaO2-FiO2, Respiratory Rate
-
Treatment
Other
-
Trial Participants
40
Hunan
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events
-
Treatment
LPV/r, LPV/r + Other, Other
-
Trial Participants
90
Hunan
-
COVID-19 status
Confirmed
-
Outcome
PaO2-FiO2, Respiratory Rate, Radiographic Findings
-
Treatment
Antivirals, TCM + Antiviral
-
Trial Participants
40
Hunan
-
COVID-19 status
Healthy
-
Outcome
Adverse Events, IL-2, IL-4, IL-6, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
900
Hunan
-
COVID-19 status
Healthy
-
Outcome
Quality of Life
-
Treatment
TCM
-
Trial Participants
1000
Hunan
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
SOC, Stem cells
-
Trial Participants
60
Hunan
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance, Radiographic Findings
-
Treatment
Stem cells
-
Trial Participants
20
Hunan
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
NA
-
Treatment
SOC, TCM
-
Trial Participants
100
Hunan
-
COVID-19 status
Suspected
-
Outcome
Anxiety
-
Treatment
Psychological therapy, SOC
-
Trial Participants
51
Idaho
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Adverse Events
-
Treatment
Razuprotafib, SOC
-
Trial Participants
180
Idaho
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Idaho
-
COVID-19 status
Confirmed
-
Outcome
Fever, Serious Adverse Events, Platelet Count, ALT, AST, Albumin, Bilirubin, Blood Pressure, Heart Rate, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
Idaho
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Cardiac Outcome (Unspecified)
-
Treatment
HCQ, SOC
-
Trial Participants
120
Idaho
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Idaho
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
174
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Fever, Other Mild Symptoms, Adverse Events
-
Treatment
HCQ
-
Trial Participants
20
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance, Treatment-emergent Adverse Events, Weight, Height or BMI
-
Treatment
Remdesivir, SOC
-
Trial Participants
1230
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, Antibodies
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
24
Illinois
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1000
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, C-Reactive Protein
-
Treatment
SOC, TCZ
-
Trial Participants
332
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Renal Outcome (Unspecified)
-
Treatment
SOC, Triterpenes
-
Trial Participants
440
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
573
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2
-
Treatment
mAb, SOC
-
Trial Participants
384
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Illinois
-
COVID-19 status
NA
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Fever, Other Mild Symptoms, Adverse Events
-
Treatment
DMARD
-
Trial Participants
20
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
Illinois
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Serious Adverse Events
-
Treatment
Anticoagulants, SOC
-
Trial Participants
600
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Fever, Ferritin, Lymphocyte Count, D-Dimer, LDH
-
Treatment
Other, SOC
-
Trial Participants
30
Illinois
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
TCZ
-
Trial Participants
32
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Fever
-
Treatment
Antiretroviral + Dexamethasone, Other, Other + Antiretroviral, Other + Dexamethasone
-
Trial Participants
525
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Illinois
-
COVID-19 status
NA
-
Outcome
Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2
-
Treatment
Positioning
-
Trial Participants
500
Illinois
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Visits or Returns to Emergency Department
-
Treatment
Anticoagulants, SOC
-
Trial Participants
4000
Illinois
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospitalization
-
Treatment
mAb, SOC
-
Trial Participants
376
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin, LDH
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Illinois
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Non-invasive respiratory support, Positioning + Non-invasive respiratory support
-
Trial Participants
346
Illinois
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, Troponin
-
Treatment
SOC, SSRIs
-
Trial Participants
152
Illinois
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
Illinois
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
Illinois
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
20
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, Ferritin, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + mAb
-
Trial Participants
200
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, LDH
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
50
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Illinois
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin
-
Treatment
mAb, SOC
-
Trial Participants
270
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
150
Illinois
-
COVID-19 status
Confirmed
-
Outcome
D-Dimer
-
Treatment
Other, SOC
-
Trial Participants
80
Illinois
-
COVID-19 status
NA
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
10
Illinois
-
COVID-19 status
NA
-
Outcome
Hospitalization
-
Treatment
Anticoagulants, Antihypertensive, SOC
-
Trial Participants
7000
Illinois
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
SOC, Stem cells
-
Trial Participants
30
Incheon
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
76
Incheon
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings
-
Treatment
Monoclonal antibody
-
Trial Participants
18
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2
-
Treatment
mAb, SOC
-
Trial Participants
384
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Indiana
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospitalization
-
Treatment
mAb, SOC
-
Trial Participants
376
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Indiana
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Indiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
Inner Mongol
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, White Blood Cell Count, Monocyte Count, Natural Killer Cell Count, Neutrophils, Creatinine Phosphokinase, CK-MB, eGFR, ALT, Albumin, Bilirubin, Urine Sample, Radiographic Findings
-
Treatment
TCM
-
Trial Participants
60
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
52
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
208
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Iowa
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Iowa
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Iowa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
mAb, SOC
-
Trial Participants
124
Islamabad
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), C-Reactive Protein, D-Dimer
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
75
Islamabad
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
30
Islamabad
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
NA
-
Trial Participants
500
Islamabad
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Other Mild Symptoms, Treatment-emergent Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
200
Islamabad
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Islamabad
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Islamabad
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Plasma based therapy, Plasma based therapy + TCZ + Remdesivir + Stem cells, SOC
-
Trial Participants
600
Islamabad
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Islamabad
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Ivermectin, SOC
-
Trial Participants
100
Islamabad
-
COVID-19 status
Suspected
-
Outcome
Mortality
-
Treatment
ARBs, ARBs + Statins, NSAIDs, NSAIDs + ARBs, NSAIDs + ARBs + Statins, NSAIDs + Statins, Statins
-
Trial Participants
10000
Istanbul
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Istanbul
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Other, SOC
-
Trial Participants
200
Istanbul
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Istanbul
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
SOC, Stem cells
-
Trial Participants
30
Istanbul
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Antihypertensive, SOC
-
Trial Participants
20
Istanbul
-
COVID-19 status
Healthy
-
Outcome
Mortality
-
Treatment
Alternative therapy, SOC
-
Trial Participants
50
Istanbul
-
COVID-19 status
NA
-
Outcome
Dyspnea, Other Mild Symptoms, Depression, Anxiety
-
Treatment
Education, Non-invasive respiratory support
-
Trial Participants
270
Istanbul
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
NA
-
Treatment
Inhaled solution, SOC
-
Trial Participants
60
Izmir
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Fever, Dyspnea, Blood Pressure, Heart Rate, SpO2, Respiratory Rate
-
Treatment
AZT + Oseltamivir, Stem cells + AZT + Oseltamivir
-
Trial Participants
40
Jakarta
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Fever, C-Reactive Protein, IL-6, Lymphocyte Count, PaO2-FiO2, SpO2
-
Treatment
Other, SOC
-
Trial Participants
368
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, C-Reactive Protein, D-Dimer, INR, Radiographic Findings
-
Treatment
Plasma based therapy
-
Trial Participants
10
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Treatment-emergent Adverse Events
-
Treatment
SOC, Stem cells
-
Trial Participants
9
Jakarta
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, IL-6, D-Dimer, PaO2-FiO2
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
60
Jakarta
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge
-
Treatment
Immunomodulators, SOC
-
Trial Participants
256
Jalisco
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Jalisco
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Patient Positioning
-
Treatment
Positioning, SOC
-
Trial Participants
200
Jalisco
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Ivermectin, SOC
-
Trial Participants
66
Jalisco
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
410
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
420
Jerusalem
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
Other
-
Trial Participants
5
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
40
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
Other, SOC
-
Trial Participants
40
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Platelet Count, PaO2-FiO2
-
Treatment
Apoptotic cells
-
Trial Participants
5
Jerusalem
-
COVID-19 status
NA
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Cough, Dyspnea, Other Mild Symptoms, Adverse Events, Anti SARS-COV-2 Titers, C-Reactive Protein, Ferritin, IL-1, IL-2, IL-6, IL-10, Tumor Necrosis Factor (Any), White Blood Cell Count, Erythrocyte Sedimentation Rate, Procalcitonin, IgG, IgM or IgA, Antibodies, PaO2-FiO2
-
Treatment
Non-invasive respiratory support
-
Trial Participants
30
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, Stem cells
-
Trial Participants
140
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance
-
Treatment
HCQ, SOC
-
Trial Participants
5
Jerusalem
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Fever
-
Treatment
HCQ, SOC
-
Trial Participants
1300
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
230
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Jerusalem
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA)
-
Treatment
Dexamethasone, SOC
-
Trial Participants
299
Jerusalem
-
COVID-19 status
NA
-
Outcome
Mortality, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1300
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
270
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
260
Jerusalem
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, HCQ + Other, SOC
-
Trial Participants
250
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance
-
Treatment
Hygiene
-
Trial Participants
70
Jerusalem
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Quality of Life
-
Treatment
HCQ, HCQ + AZT
-
Trial Participants
440
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, D-Dimer, Troponin
-
Treatment
Anticoagulants
-
Trial Participants
600
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
IFN, SOC
-
Trial Participants
40
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
SOC, TCZ
-
Trial Participants
500
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Platelet Count, PaO2-FiO2
-
Treatment
Cell-based therapeutic
-
Trial Participants
24
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious or Seconday Infections, Serious Adverse Events, ALT
-
Treatment
Sarilumab, SOC
-
Trial Participants
460
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, SpO2
-
Treatment
Other, SOC
-
Trial Participants
50
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Jerusalem
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Ivermectin, SOC
-
Trial Participants
100
Jiangsu
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation, White Blood Cell Count, Creatinine Phosphokinase, CK-MB, ALT, PaO2-FiO2, Respiratory Rate
-
Treatment
SOC, TCM
-
Trial Participants
50
Jiangsu
-
COVID-19 status
NA
-
Outcome
Serious or Seconday Infections, Adverse Events, Anti SARS-COV-2 Titers
-
Treatment
SOC, Vaccine
-
Trial Participants
500
Jiangsu
-
COVID-19 status
Healthy
-
Outcome
Urine Sample, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
144
Jiangsu
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Fever, Dyspnea, Other Mild Symptoms, C-Reactive Protein, White Blood Cell Count, Erythrocyte Sedimentation Rate, Procalcitonin
-
Treatment
SOC, TCM
-
Trial Participants
100
Jiangsu
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance, White Blood Cell Count, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
26
Jiangsu
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, C-Reactive Protein, IL-6, LDH, Respiratory Rate, Renal Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
90
Jiangsu
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
FPV
-
Trial Participants
9
Jiangsu
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Adverse Events, Weight, Height or BMI, Antibodies, Blood Pressure, ECG
-
Treatment
mAb, SOC
-
Trial Participants
456
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
LPV/r, LPV/r + TCM
-
Trial Participants
80
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Fever, C-Reactive Protein, Erythrocyte Sedimentation Rate, CD4, Respiratory Rate, Radiographic Findings
-
Treatment
SOC, TCM
-
Trial Participants
120
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Treatment-emergent Adverse Events
-
Treatment
SOC, Stem cells + Natural Killer Cells
-
Trial Participants
20
Jiangxi
-
COVID-19 status
Resolved
-
Outcome
Fever, Respiratory Rate, 6-Minute Walking Distance, Quality of Life, Depression, Anxiety, Distress
-
Treatment
Exercise, Exercise + Respiratory support, Respiratory support
-
Trial Participants
108
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever
-
Treatment
SOC, TCM
-
Trial Participants
72
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Viral Load or Clearance
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
100
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
Stem cells
-
Trial Participants
16
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Dyspnea, C-Reactive Protein, ALT, Bilirubin, Antibodies
-
Treatment
Plasma based therapy
-
Trial Participants
10
Jiangxi
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
DAA, IFN, TCM
-
Trial Participants
50
Jilin
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Cough, Fever, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
HCQ
-
Trial Participants
10
Kabul
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Kaluga
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
mAb, SOC
-
Trial Participants
206
Kampala
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Kampala
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Kanagawa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Kanagawa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
Kanagawa
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Kanagawa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Kandahar
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Kansas
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1000
Kansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Pneumonia or ARDS, Non-invasive Ventilation, Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Bicarbonates
-
Treatment
ARBs
-
Trial Participants
34
Kansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Remdesivir + Costimulation blocker, Remdesivir + mAb, Remdesivir + Other
-
Trial Participants
2160
Kansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Kansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Kansas
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Kansas
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
260
Kansas
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, Fever, Serious Adverse Events, IL-1, IL-8, Tumor Necrosis Factor (Any), SpO2, Distress
-
Treatment
Other, SOC
-
Trial Participants
36
Kansas
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Other, SOC
-
Trial Participants
174
Karnataka
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ + AZT, SOC
-
Trial Participants
4000
Karnataka
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge
-
Treatment
Psychological therapy, SOC
-
Trial Participants
40
Karnataka
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Organ Failure or Dysfunction (SOFA), Antibodies, PaO2-FiO2, SpO2, Radiographic Findings, Distress, Renal Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
24
Kathmandu
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Alternative therapy, SOC
-
Trial Participants
100
Kayseri
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Kayseri
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other
-
Trial Participants
60
Kent
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, Antibodies
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
24
Kentucky
-
COVID-19 status
Healthy
-
Outcome
Mortality, Serious Adverse Events, Interferon (Any), Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
6578
Kentucky
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
Vaccine
-
Trial Participants
120
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
61
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, PaO2-FiO2, Radiographic Findings, Hypoxia
-
Treatment
Inhaled solution, SOC
-
Trial Participants
144
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
mAb, SOC
-
Trial Participants
300
Kentucky
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
180
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
479
Kentucky
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Deep Vein Thrombosis or Pulmonary Embolism, Renal Outcome (Unspecified)
-
Treatment
Other
-
Trial Participants
366
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Kentucky
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Kentucky
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
260
Kentucky
-
COVID-19 status
NA
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Fever, Dyspnea, Other Mild Symptoms
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
600
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Serious Adverse Events
-
Treatment
Immunomodulators, SOC
-
Trial Participants
129
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Distress
-
Treatment
Igs, SOC
-
Trial Participants
100
Kentucky
-
COVID-19 status
Confirmed
-
Outcome
Mortality, C-Reactive Protein, Ferritin, IL-6, Lymphocyte Count, D-Dimer
-
Treatment
Plasma based therapy
-
Trial Participants
100
Kerman
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Stem cells
-
Trial Participants
10
Kerman
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Cough, Fever, Dyspnea, Other Mild Symptoms, SpO2, Respiratory Rate
-
Treatment
Alternative therapy, SOC
-
Trial Participants
80
Kermanshah
-
COVID-19 status
Confirmed
-
Outcome
Mortality
-
Treatment
Other, SOC
-
Trial Participants
50
Kermanshah
-
COVID-19 status
Confirmed
-
Outcome
Radiographic Findings
-
Treatment
Ivermectin, SOC
-
Trial Participants
50
Kermanshah
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), C-Reactive Protein, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
50
Khartoum
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Viral Load or Clearance
-
Treatment
Other
-
Trial Participants
110
Khartoum
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Khuzestan
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge
-
Treatment
HCQ + LPV/r, HCQ + LPV/r + Ivermectin
-
Trial Participants
60
Khuzestan
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Cough, Fever, Dyspnea, Other Mild Symptoms
-
Treatment
DAA, SOC
-
Trial Participants
1000
Khuzestan
-
COVID-19 status
NA
-
Outcome
Cough, Fever, Dyspnea
-
Treatment
Other, SOC, Vitamins, Vitamins + Other
-
Trial Participants
100
Khuzestan
-
COVID-19 status
Confirmed
-
Outcome
Platelet Count
-
Treatment
Alternative therapy, SOC
-
Trial Participants
88
Kigali
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Mortality, Hospital Discharge, Pneumonia or ARDS, Distress
-
Treatment
HCQ, HCQ + LPV/r, LPV/r, SOC
-
Trial Participants
6400
Kinshasa
-
COVID-19 status
Confirmed
-
Outcome
Mortality, SpO2
-
Treatment
HCQ, LPV/r, SOC
-
Trial Participants
3000
Kirov
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Radiographic Findings
-
Treatment
FPV, SOC
-
Trial Participants
330
Kocaeli
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
13000
Konya
-
COVID-19 status
Confirmed
-
Outcome
Other Mild Symptoms, Quality of Life, Depression, Anxiety
-
Treatment
Education, Exercise, Respiratory support
-
Trial Participants
36
Krasnoyarsk
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Kuala Lumpur
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance
-
Treatment
Hygiene, SOC
-
Trial Participants
20
Kuala Lumpur
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation
-
Treatment
Corticosteroids, TCZ
-
Trial Participants
310
Kuala Lumpur
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
230
Kuala Lumpur
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Kuala Lumpur
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Kuala Lumpur
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
Kuwait City
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Radiographic Findings, Hypoxia
-
Treatment
FPV, SOC
-
Trial Participants
780
Kuwait City
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Cyclosporin + Steroids
-
Trial Participants
12
Kuwait City
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Kuwait City
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
300
Kyiv (Kiev)
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein
-
Treatment
Other, SOC
-
Trial Participants
100
Kyiv (Kiev)
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Pneumonia or ARDS, Cough, Fever, C-Reactive Protein, PaO2-FiO2
-
Treatment
Antibiotics + AZT + Corticosteroids + Anticoagulants + Other, Stem cells + Antibiotics + AZT + Corticosteroids + Anticoagulants + Other
-
Trial Participants
30
Kyiv (Kiev)
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
60000
Kyiv (Kiev)
-
COVID-19 status
Confirmed
-
Outcome
Invasive Mechanical Ventilation or ECMO, Fever, Other Mild Symptoms, Adverse Events, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
190
Kyiv (Kiev)
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
222
Kyiv (Kiev)
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Fever, Lymphocyte Count
-
Treatment
Igs, SOC
-
Trial Participants
76
La Rioja
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Lacs
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein
-
Treatment
LPV/r, LPV/r + Immunomodulators, LPV/r + Statins
-
Trial Participants
294
Lancashire
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
1450
Las Palmas
-
COVID-19 status
Healthy
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
HCQ, HCQ + NRTIs, NRTIs, SOC
-
Trial Participants
4000
Lecco
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
Leeds
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
Antivirals, SOC
-
Trial Participants
130
Leeds
-
COVID-19 status
Healthy
-
Outcome
IgG, IgM or IgA
-
Treatment
SOC, Vitamins
-
Trial Participants
4400
Leeds
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Leeds
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
Leeds
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Liaoning
-
COVID-19 status
Confirmed
-
Outcome
Pneumonia or ARDS, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
45
Liaoning
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Depression, Anxiety, Distress
-
Treatment
TCM
-
Trial Participants
60
Liaoning
-
COVID-19 status
Confirmed
-
Outcome
Depression, Anxiety
-
Treatment
Rehabilitation
-
Trial Participants
160
Liaoning
-
COVID-19 status
Confirmed
-
Outcome
Viral Load or Clearance, Adverse Events, Serious Adverse Events, PaO2-FiO2, Respiratory Rate
-
Treatment
DAA, SOC
-
Trial Participants
20
Liaoning
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Quality of Life
-
Treatment
TCM, TCM + Psychological therapy
-
Trial Participants
60
Liege
-
COVID-19 status
NA
-
Outcome
Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
260
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
192
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
573
Lima
-
COVID-19 status
NA
-
Outcome
Invasive Mechanical Ventilation or ECMO
-
Treatment
SOC, TCZ
-
Trial Participants
379
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Lima
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
60000
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, LPV/r, Remdesivir, SOC
-
Trial Participants
7000
Lima
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
140
Lima
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
Lima
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
10000
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Lima
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Other, SOC
-
Trial Participants
1034
Lima
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, SpO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
177
Limburg
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Viral Load or Clearance, Organ Failure or Dysfunction (SOFA)
-
Treatment
Broad- spectrum sorbent hemoperfusion device, SOC
-
Trial Participants
42
Lisbon
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose, Blood Pressure, Heart Rate, SpO2, Pregnancy or Birth Outcomes
-
Treatment
Other, SOC
-
Trial Participants
NA
Lisbon
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events, White Blood Cell Count, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose, Renal Outcome (Unspecified)
-
Treatment
HCQ, LPV/r, Remdesivir
-
Trial Participants
3100
Liverpool
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Liverpool
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Liverpool
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Liverpool
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, SpO2
-
Treatment
Other, SOC
-
Trial Participants
1034
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Non-invasive Ventilation
-
Treatment
Other, SOC
-
Trial Participants
NA
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Hospitalization, Clinical Improvement Score (Any), Other Mild Symptoms, Adverse Events
-
Treatment
Hygiene, SOC
-
Trial Participants
405
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)
-
Treatment
NA
-
Trial Participants
20000
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Pneumonia or ARDS
-
Treatment
AZT, SOC
-
Trial Participants
800
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
IL-1, IL-6
-
Treatment
Anakinra, SOC
-
Trial Participants
40
London
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Viral Load or Clearance, Adverse Events, Blood Pressure, Heart Rate, ECG, SpO2, Respiratory Rate, Renal Outcome (Unspecified)
-
Treatment
Anticoagulants, Other, SOC
-
Trial Participants
NA
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, von Wildebrandt Factor, Troponin, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
NA
London
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Pneumonia or ARDS, Cough, Fever, Dyspnea, Other Mild Symptoms, Blood Pressure, Heart Rate, SpO2, Respiratory Rate
-
Treatment
IFN, SOC
-
Trial Participants
400
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Blood Gas, PaO2-FiO2, Respiratory Rate, Blood pH
-
Treatment
Other, SOC
-
Trial Participants
85
London
-
COVID-19 status
NA
-
Outcome
Adverse Events, Serious Adverse Events, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
24
London
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Serious or Seconday Infections, Adverse Events, Anti SARS-COV-2 Titers
-
Treatment
Vaccine
-
Trial Participants
1112
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Renal Outcome (Unspecified)
-
Treatment
Immunomodulators, JAKi, SOC
-
Trial Participants
456
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Fever, Adverse Events, Bilirubin, Stool Sample
-
Treatment
FPV, LPV/r, LPV/r + FPV, SOC
-
Trial Participants
240
London
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
London
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
1034
London
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), SpO2
-
Treatment
mAb, SOC
-
Trial Participants
270
London
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events
-
Treatment
Radiation therapy
-
Trial Participants
13
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance
-
Treatment
FPV, LPV/r, LPV/r + FPV, SOC
-
Trial Participants
240
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, IL-6, Tumor Necrosis Factor (Any), D-Dimer, Angiotensins, ACE, ECG, SpO2
-
Treatment
Other, SOC
-
Trial Participants
465
London
-
COVID-19 status
Suspected
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
3000
London
-
COVID-19 status
Suspected
-
Outcome
Mortality, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Adverse Events
-
Treatment
AZT, SOC
-
Trial Participants
800
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Labor Absenteeism, Fever, SpO2, Respiratory Rate
-
Treatment
Other, SOC
-
Trial Participants
230
London
-
COVID-19 status
Healthy
-
Outcome
Stool Sample, CD4
-
Treatment
SOC, Vaccine
-
Trial Participants
12390
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea, Hyper-Inflammation, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Deep Vein Thrombosis or Pulmonary Embolism, Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6, Tumor Necrosis Factor (Any), White Blood Cell Count, D-Dimer, Creatinine Phosphokinase, Bilirubin, Glucose, Antibodies, PaO2-FiO2, Radiographic Findings, Lung Inflamation, Hypoxemia, Quality of Life
-
Treatment
SOC, TCZ
-
Trial Participants
450
London
-
COVID-19 status
Confirmed
-
Outcome
Treatment-emergent Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
2500
London
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Other Mild Symptoms, Adverse Events
-
Treatment
HCQ, SOC
-
Trial Participants
NA
London
-
COVID-19 status
Suspected
-
Outcome
Viral Load or Clearance
-
Treatment
Alternative therapy, SOC
-
Trial Participants
120
London
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
Hygien, SOC
-
Trial Participants
300
London
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Fibrinogen, PaO2-FiO2
-
Treatment
Anticoagulants, SOC
-
Trial Participants
36
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
London
-
COVID-19 status
Confirmed
-
Outcome
C-Reactive Protein
-
Treatment
Other, SOC
-
Trial Participants
100
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
300
London
-
COVID-19 status
Confirmed Or Healthy
-
Outcome
Mortality, Hospital Discharge, Pneumonia or ARDS, Distress
-
Treatment
HCQ, HCQ + LPV/r, LPV/r, SOC
-
Trial Participants
6400
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, SpO2, Respiratory Rate
-
Treatment
FPV, HCQ + AZT + Zinc, SOC
-
Trial Participants
450
London
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
40000
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Serious or Seconday Infections, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, CD4, CD8
-
Treatment
Other, SOC
-
Trial Participants
48
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
150
London
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
52
London
-
COVID-19 status
NA
-
Outcome
Hospitalization, Viral Load or Clearance, Other Mild Symptoms
-
Treatment
HCQ, SOC
-
Trial Participants
1000
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Renal Outcome (Unspecified)
-
Treatment
JAKi, mAb, SOC
-
Trial Participants
375
London
-
COVID-19 status
NA
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, C-Reactive Protein, PaO2-FiO2
-
Treatment
Inhaled solution, SOC
-
Trial Participants
50
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, SpO2, Respiratory Rate
-
Treatment
JAKi, SOC
-
Trial Participants
1000
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, Blood Pressure, Heart Rate, Respiratory Rate, Quality of Life
-
Treatment
Other, SOC
-
Trial Participants
1800
London
-
COVID-19 status
NA
-
Outcome
Mortality, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, Fibrinogen, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
24
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
FPV, HCQ + AZT + Zinc, SOC
-
Trial Participants
450
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other, SOC
-
Trial Participants
222
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Viral Load or Clearance
-
Treatment
Hygiene, SOC
-
Trial Participants
40
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, LDH
-
Treatment
Antihypertensive, SOC
-
Trial Participants
200
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Antihypertensive, SOC
-
Trial Participants
60
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
DPP1 inhibitor, SOC
-
Trial Participants
300
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Serious Adverse Events
-
Treatment
Other, SOC
-
Trial Participants
150
London
-
COVID-19 status
Confirmed
-
Outcome
Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, Troponin, Prothrombin, Fibrinogen, Coagulation Test, Triglycerides, Electrolytes, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, Blood Pressure, Heart Rate, ECG, Respiratory Rate, Bicarbonates
-
Treatment
Anticoagulants, Other, SOC
-
Trial Participants
100
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
IFN, SOC
-
Trial Participants
220
London
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
SOC, SOC + Vaccine, Vaccine, Vaccine + Vaccine
-
Trial Participants
9000
London
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
London
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Pneumonia or ARDS, Organ Failure or Dysfunction (SOFA), C-Reactive Protein, D-Dimer, Procalcitonin
-
Treatment
Inhaled solution, SOC
-
Trial Participants
40
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, Radiographic Findings
-
Treatment
JAKi
-
Trial Participants
NA
London
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
1090
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Fever, Serious or Seconday Infections, Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, Neutrophils, D-Dimer, Triglycerides, LDH, PaO2-FiO2, SpO2, Respiratory Rate
-
Treatment
mAb, Other
-
Trial Participants
NA
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, SpO2
-
Treatment
JAKi, SOC
-
Trial Participants
402
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Non-invasive Ventilation
-
Treatment
Other, SOC
-
Trial Participants
389
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, LDH
-
Treatment
Other, SOC
-
Trial Participants
230
London
-
COVID-19 status
Healthy
-
Outcome
Serious Adverse Events
-
Treatment
Vaccine
-
Trial Participants
12330
London
-
COVID-19 status
Resolved
-
Outcome
Adverse Events
-
Treatment
Psychological therapy, SOC
-
Trial Participants
26
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, Renal Outcome (Unspecified)
-
Treatment
JAKi, mAb, SOC
-
Trial Participants
NA
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, SpO2
-
Treatment
NSAIDs, SOC
-
Trial Participants
NA
London
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Non-invasive Ventilation
-
Treatment
Remdesivir, SOC
-
Trial Participants
400
London
-
COVID-19 status
Healthy
-
Outcome
Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
60
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2
-
Treatment
NSAIDs, SOC
-
Trial Participants
230
London
-
COVID-19 status
Confirmed
-
Outcome
Fever, Other Mild Symptoms, Serious Adverse Events, IgG, IgM or IgA, Antibodies
-
Treatment
Vaccine
-
Trial Participants
320
London
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
500
London
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
SGLT2, SOC
-
Trial Participants
900
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Hygiene
-
Trial Participants
22
London
-
COVID-19 status
Healthy
-
Outcome
Viral Load or Clearance, Pneumonia or ARDS
-
Treatment
HCQ, SOC
-
Trial Participants
40000
London
-
COVID-19 status
NA
-
Outcome
ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
JAKi, SOC
-
Trial Participants
402
London
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
40000
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Platelet Count, Hemoglobin, ALT, SpO2, Radiographic Findings
-
Treatment
Other, SOC
-
Trial Participants
250
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Glucose, Surfactant Factor Protein, PaO2-FiO2
-
Treatment
Other, SOC
-
Trial Participants
20
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Renal Outcome (Unspecified)
-
Treatment
Oseltamivir, Oseltamivir + Other
-
Trial Participants
120
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Other
-
Trial Participants
2000
London
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Lymphocyte Count
-
Treatment
Other, SOC
-
Trial Participants
48
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, ALT, AST, Bilirubin
-
Treatment
DPP1 inhibitor, SOC
-
Trial Participants
300
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
London
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
FPV, SOC
-
Trial Participants
302
London
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Labor Absenteeism, Pneumonia or ARDS, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Adverse Events
-
Treatment
Vaccine
-
Trial Participants
10078
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospital Discharge, SpO2
-
Treatment
Other, SOC
-
Trial Participants
300
London
-
COVID-19 status
Confirmed
-
Outcome
Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Adverse Events, C-Reactive Protein, Ferritin, IL-6, IL-10, Tumor Necrosis Factor (Any)
-
Treatment
Other, SOC
-
Trial Participants
106
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Serious Adverse Events, SpO2
-
Treatment
Other, SOC
-
Trial Participants
90
London
-
COVID-19 status
Suspected
-
Outcome
Visits or Returns to Emergency Department, Viral Load or Clearance, Fever, SpO2
-
Treatment
Corticosteroids, SOC
-
Trial Participants
478
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO
-
Treatment
Other, SOC
-
Trial Participants
300
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Clinical Improvement Score (Any)
-
Treatment
IFN, SOC
-
Trial Participants
820
London
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, D-Dimer, LDH, SpO2, Renal Outcome (Unspecified)
-
Treatment
Other, Other + SGLT2, SOC
-
Trial Participants
1407
London
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Louisiana
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Deep Vein Thrombosis or Pulmonary Embolism, Quality of Life, Renal Outcome (Unspecified), Cardiac Outcome (Unspecified)
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1000
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB, SOC
-
Trial Participants
2104
Louisiana
-
COVID-19 status
NA
-
Outcome
Mortality, ICU Admission, Hospitalization, Viral Load or Clearance, Non-invasive Ventilation
-
Treatment
NA
-
Trial Participants
48
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
70
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, Remdesivir + JAKi
-
Trial Participants
1034
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Clinical Improvement Score (Any)
-
Treatment
mAb, SOC
-
Trial Participants
573
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Treatment-emergent Adverse Events, D-Dimer, Antibodies, PaO2-FiO2, SpO2
-
Treatment
mAb, SOC
-
Trial Participants
384
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Weight, Height or BMI, Antibodies
-
Treatment
mAB
-
Trial Participants
2970
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Immunomodulators, SOC
-
Trial Participants
38
Louisiana
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, Vitamins
-
Trial Participants
829
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
NA
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
200
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Invasive Mechanical Ventilation or ECMO
-
Treatment
SOC, Trpc6 inhibitor
-
Trial Participants
90
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, Troponin, Fibrinogen, INR, ALT, AST, Albumin, Bilirubin, Glucose, LDH, IgG, IgM or IgA, Blood Urea Nitrogen, Blood Pressure, SpO2, Radiographic Findings
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
208
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Fever, Adverse Events, Antibodies, SpO2
-
Treatment
Other, SOC
-
Trial Participants
2000
Louisiana
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
SOC, Vaccine
-
Trial Participants
60
Louisiana
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
Mortality
-
Treatment
SOC, Vaccine
-
Trial Participants
96
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Clinical Improvement Score (Any), Adverse Events
-
Treatment
Remdesivir
-
Trial Participants
4891
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization
-
Treatment
Antihypertensive, Antihypertensive + Nutrition, SOC
-
Trial Participants
1080
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, Bilirubin
-
Treatment
Remdesivir
-
Trial Participants
52
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
HCQ, SOC
-
Trial Participants
479
Louisiana
-
COVID-19 status
NA
-
Outcome
Labor Absenteeism
-
Treatment
HCQ, SOC
-
Trial Participants
1700
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Antibodies
-
Treatment
Remdesivir, Remdesivir + Other
-
Trial Participants
10000
Louisiana
-
COVID-19 status
Healthy
-
Outcome
Visits or Returns to Emergency Department, Antibodies
-
Treatment
SOC, Vaccine
-
Trial Participants
40051
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, White Blood Cell Count, Monocyte Count, Lymphocyte Count, Neutrophils, Platelet Count, Hemoglobin, Prothrombin, ALT, AST, Bilirubin, Glucose
-
Treatment
Remdesivir, SOC
-
Trial Participants
1062
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Non-invasive Ventilation, Serious Adverse Events
-
Treatment
Monoclonal antibody, SOC
-
Trial Participants
1360
Louisiana
-
COVID-19 status
Healthy
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Cough, Fever, Dyspnea
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
500
Louisiana
-
COVID-19 status
NA
-
Outcome
Clinical Improvement Score (Any), Viral Load or Clearance, Adverse Events
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
20
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Non-invasive Ventilation, Treatment-emergent Adverse Events
-
Treatment
Remdesivir, SOC
-
Trial Participants
1113
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, C-Reactive Protein, IL-6, White Blood Cell Count, Platelet Count, Hemoglobin, ALT, AST, Bilirubin, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
1912
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Serious Adverse Events, Antibodies
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
1344
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, C-Reactive Protein, White Blood Cell Count, Platelet Count, Hemoglobin, D-Dimer, INR, ALT, AST, Bilirubin
-
Treatment
Remdesivir, Remdesivir + IFN
-
Trial Participants
969
Louisiana
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
Plasma based therapy
-
Trial Participants
NA
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, ALT, Bilirubin
-
Treatment
mAb, SOC
-
Trial Participants
270
Louisiana
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Organ Failure or Dysfunction (SOFA), Adverse Events
-
Treatment
JAKi, SOC
-
Trial Participants
500
Louisiana
-
COVID-19 status
NA
-
Outcome
NA
-
Treatment
HCQ, HCQ + AZT, SOC
-
Trial Participants
600
Lucerne
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Clinical Improvement Score (Any), C-Reactive Protein, Hemoglobin, D-Dimer, eGFR, Glucose, Renal Outcome (Unspecified)
-
Treatment
mAb, SOC
-
Trial Participants
116
Lusaka
-
COVID-19 status
Healthy
-
Outcome
NA
-
Treatment
HCQ, SOC
-
Trial Participants
30000
Luxembourg
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious Adverse Events, Platelet Count, Hemoglobin, Prothrombin, Electrolytes, INR, ALT, AST, Bilirubin, Glucose
-
Treatment
HCQ, LPV/r, LPV/r + IFN, Remdesivir, SOC
-
Trial Participants
3100
Madhya Pradesh
-
COVID-19 status
Confirmed
-
Outcome
Mortality, Hospitalization, Clinical Improvement Score (Any), Non-invasive Ventilation, Organ Failure or Dysfunction (SOFA)
-
Treatment
Other, SOC
-
Trial Participants
40
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Invasive Mechanical Ventilation or ECMO, Treatment-emergent Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, SpO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
177
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, PaO2-FiO2, Blood pH
-
Treatment
Colchicine, SOC
-
Trial Participants
6000
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Ferritin, Lymphocyte Count, Platelet Count, Hemoglobin, D-Dimer, ALT, Bilirubin, LDH, SpO2, Hypoxemia
-
Treatment
Corticosteroids, Siltuximab
-
Trial Participants
200
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Organ Failure or Dysfunction (SOFA), Adverse Events, Distress
-
Treatment
HCQ, SOC
-
Trial Participants
NA
Madrid
-
COVID-19 status
NA
-
Outcome
Mortality, Invasive Mechanical Ventilation or ECMO, Organ Failure or Dysfunction (SOFA), Serious Adverse Events, Radiographic Findings
-
Treatment
HCQ + AZT or LPV/r + IFN, Plasma based therapy
-
Trial Participants
72
Madrid
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospital Discharge, Clinical Improvement Score (Any), Viral Load or Clearance, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Serious or Seconday Infections, Organ Failure or Dysfunction (SOFA), Adverse Events, Serious Adverse Events, C-Reactive Protein, Ferritin, IL-6
-
Treatment
Dexamethasone, SOC
-
Trial Participants
200
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Invasive Mechanical Ventilation or ECMO
-
Treatment
Melatonin, SOC
-
Trial Participants
NA
Madrid
-
COVID-19 status
Confirmed Or Suspected
-
Outcome
ICU Admission, Hospitalization, Clinical Improvement Score (Any), Adverse Events, Treatment-emergent Adverse Events, Serious Adverse Events
-
Treatment
JAKi + Statins, SOC
-
Trial Participants
94
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Hospital Discharge, Invasive Mechanical Ventilation or ECMO, Ferritin, IL-6, IL-10, IL-12, Lymphocyte Count, D-Dimer, Troponin
-
Treatment
Other, SOC
-
Trial Participants
NA
Madrid
-
COVID-19 status
Resolved
-
Outcome
NA
-
Treatment
Psychological therapy, SOC
-
Trial Participants
150
Madrid
-
COVID-19 status
Confirmed
-
Outcome
ICU Admission, Hospitalization, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Fever, Serious Adverse Events, Respiratory Rate, Hypoxemia
-
Treatment
Sarilumab, SOC
-
Trial Participants
420
Madrid
-
COVID-19 status
NA
-
Outcome
Mortality, Hospital Discharge, Clinical Improvement Score (Any), Ferritin, Lymphocyte Count, Neutrophils
-
Treatment
Non-invasive respiratory support, SOC
-
Trial Participants
208
Madrid
-
COVID-19 status
NA
-
Outcome
Mortality, Clinical Improvement Score (Any), Viral Load or Clearance, Invasive Mechanical Ventilation or ECMO, Adverse Events, Treatment-emergent Adverse Events, C-Reactive Protein, IL-6, MCP-1, Dendritic Cell Count, D-Dimer, Coagulation Test, ALT, Glucose, LDH
-
Treatment
Plasma based therapy, SOC
-
Trial Participants
278
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospitalization, Hospital Discharge, Serious Adverse Events, C-Reactive Protein, Ferritin, Lymphocyte Count, PaO2-FiO2
-
Treatment
Acalabrutinib, SOC
-
Trial Participants
163
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Mortality, ICU Admission, Hospital Discharge, Non-invasive Ventilation, Invasive Mechanical Ventilation or ECMO, Adverse Events, Serious Adverse Events
-
Treatment
mAb, SOC
-
Trial Participants
800
Madrid
-
COVID-19 status
Confirmed
-
Outcome
Hospitalization, Adverse Events, C-Reactive Protein, Ferritin, D-Dimer, LDH, PaO2-FiO2